<SEC-DOCUMENT>0001731122-25-001625.txt : 20251203
<SEC-HEADER>0001731122-25-001625.hdr.sgml : 20251203
<ACCEPTANCE-DATETIME>20251202213135
ACCESSION NUMBER:		0001731122-25-001625
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251202
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251203
DATE AS OF CHANGE:		20251202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lunai Bioworks Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38758
		FILM NUMBER:		251544815

	BUSINESS ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RENOVARO INC.
		DATE OF NAME CHANGE:	20240213

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RENOVARO BIOSCIENCES INC.
		DATE OF NAME CHANGE:	20230807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Enochian Biosciences Inc.
		DATE OF NAME CHANGE:	20230804
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>e7056_8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:LNAI="http://lunaibioworks.com/20251202">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_LNAI_lunaibioworks.com_20251202 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251202_20251202 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001527728 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001527728</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lnai-20251202.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001527728</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-02</xbrli:startDate>
        <xbrli:endDate>2025-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>UNITED
S<span style="letter-spacing: -0.9pt">TA</span><span style="letter-spacing: -0.05pt">TES</span></b></span></p>

<p style="font: 14pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; letter-spacing: -0.55pt"><b>W</b></span><b><span style="font-family: Times New Roman, Times, Serif">ashington,
DC 20549</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 149.5pt 0 234.9pt; text-indent: -82.25pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>FORM
<span id="xdx_900_edei--DocumentType_c20251202__20251202_zi0XUTFVELS1"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 248.05pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPO<span style="letter-spacing: -0.3pt">R</span>T</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 246pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 or 15(d) of the <br/>
Securities Ex<span style="letter-spacing: 0.05pt">c</span>hang<span style="letter-spacing: 1.75pt">e</span>Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 213.85pt 0 226.65pt; text-indent: -10.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest ev<span style="letter-spacing: 0.05pt">e</span>nt reported): <b><span id="xdx_90C_edei--DocumentPeriodEndDate_c20251202__20251202_zSjdsgs5R3Cl"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 2, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 169.55pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.05pt"><b><span style="text-decoration: underline"><span id="xdx_90A_edei--EntityRegistrantName_c20251202__20251202_zHg8bhpVeMH"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000011" name="dei:EntityRegistrantName">LUNAI
BIOWORKS, INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of reg<span style="letter-spacing: 0.05pt">i</span>strant as specif<span style="letter-spacing: 0.05pt">i</span>ed in its chart<span style="letter-spacing: 0.05pt">e</span>r)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 139.3pt 0 135pt; text-align: center; text-indent: 6.1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20251202__20251202_z0R0qmWWzPw1"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityFileNumber_c20251202__20251202_z2tTpaOesfGf"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000013" name="dei:EntityFileNumber">001-38751</ix:nonNumeric></span></b></span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: center; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20251202__20251202_zL5xUKResc8j"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">45-2259340</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
of incorporation)</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
File Number)</span></td>
<td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer Identification
No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 139.3pt 0 135pt; text-align: center; text-indent: 6.1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20251202__20251202_zD47lyZRYJNl"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000015" name="dei:EntityAddressAddressLine1">3400
Cottage Way</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20251202__20251202_zOg8DW8ariI8"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite G2 #32562</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20251202__20251202_zEiV2bXdhxMi"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000017" name="dei:EntityAddressCityOrTown">Sacramento</ix:nonNumeric></span>,
<span id="xdx_901_edei--EntityAddressStateOrProvince_c20251202__20251202_zUxnjp7myaCg"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000018" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20251202__20251202_zQ3GfKjfBgH6"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000019" name="dei:EntityAddressPostalZipCode">95825</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">(Address
of principal execu<span style="letter-spacing: 0.05pt">t</span>ive o<span style="letter-spacing: -0.1pt">f</span>fices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 217.65pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration: underline">+1
<span id="xdx_900_edei--CityAreaCode_c20251202__20251202_zkvmeVuPOMR6"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000020" name="dei:CityAreaCode">(424)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20251202__20251202_z5J8sBhXaLfh"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000021" name="dei:LocalPhoneNumber">222-9301</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">(Registrant<span style="letter-spacing: -0.45pt">&#8217;</span>s
telephone numbe<span style="letter-spacing: -0.3pt">r</span>, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 192.6pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Check the appropria<span style="letter-spacing: 0.05pt">t</span>e
box below if the Form 8-K fi<span style="letter-spacing: 0.05pt">l</span>ing is intended to s<span style="letter-spacing: 0.05pt">i</span>multaneously
sa<span style="letter-spacing: 0.05pt">t</span>isfy the filing obl<span style="letter-spacing: 0.05pt">i</span>gation of the registr<span style="letter-spacing: 0.05pt">a</span>nt
under any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0pt; width: 5%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_903_edei--WrittenCommunications_c20251202__20251202_zhBoVI3xbIH2"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; width: 95%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_90B_edei--SolicitingMaterial_c20251202__20251202_z4ochvPFh9nj"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material
    pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_90B_edei--PreCommencementTenderOffer_c20251202__20251202_z8dlzFekiKt3"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20251202__20251202_z46CElEnpWh1"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 224.2pt 0 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 141.15pt 0 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Securities reg<span style="letter-spacing: 0.05pt">i</span>stered
pursuant to Sec<span style="letter-spacing: 0.05pt">t</span>ion 12(b) of th<span style="letter-spacing: 1.75pt">e</span>Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Title
    of Each Class</span></b></span></td>
    <td style="text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Trading
    Symbol</span></b></span></td>
    <td style="text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Name of
    Each Exchange on Which Registered</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20251202__20251202_zW5SlcbcHiEh"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value
    $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--TradingSymbol_c20251202__20251202_zsCCkk8qDZRe"><ix:nonNumeric contextRef="AsOf2025-12-02" id="Fact000027" name="dei:TradingSymbol">LNAI</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20251202__20251202_zF7B5XVViX23"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market
    LLC</ix:nonNumeric></span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Indicate by che<span style="letter-spacing: 0.05pt">c</span>k
mark whether the reg<span style="letter-spacing: 0.05pt">i</span>strant <span style="letter-spacing: 0.05pt">i</span>s an eme<span style="letter-spacing: -0.1pt">r</span>ging
grow<span style="letter-spacing: 0.05pt">t</span>h company as defined <span style="letter-spacing: 0.05pt">i</span>n Rule 405 of the
Securities Act of 1933 (&#167;230.405 of <span style="letter-spacing: 0.05pt">t</span>his ch<span style="letter-spacing: 0.05pt">a</span>pter)
or Rule 12b-2 of the Securit<span style="letter-spacing: 0.05pt">i</span>es Exchang<span style="letter-spacing: 1.75pt">e</span>Act of
1934 (&#167;240.12b-2 of this ch<span style="letter-spacing: 0.05pt">a</span>pter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Eme<span style="letter-spacing: -0.1pt">r</span>ging
growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20251202__20251202_z1A7R5gLBYk6"><ix:nonNumeric contextRef="AsOf2025-12-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif">If an eme<span style="letter-spacing: -0.1pt">r</span>ging
growth <span style="letter-spacing: 0.05pt">c</span>ompan<span style="letter-spacing: -0.55pt">y</span>, indicate by check mark if <span style="letter-spacing: 0.05pt">t</span>he
r<span style="letter-spacing: 0.05pt">e</span>gistrant has <span style="letter-spacing: 0.05pt">e</span>lected not to use the ext<span style="letter-spacing: 0.05pt">e</span>nded
tr<span style="letter-spacing: 0.05pt">a</span>nsition period for complying with any new or revised financial accounting stand<span style="letter-spacing: 0.05pt">a</span>rds
provided pursuant to Section 13(a) of the Exchang<span style="letter-spacing: 1.75pt">e </span>Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Item 1.01 Entry into a
Material Definitive Agreement. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b><br/>
On December 2, 2025, Lunai Bioworks, Inc. (the &#8220;Company&#8221;) entered into an At-the-Market Sales Agreement (the &#8220;Sales
Agreement&#8221;) with Dawson James Securities, Inc. (the &#8220;Sales Agent&#8221;), pursuant to which the Company may offer and sell
(the &#8220;Offering&#8221;) shares of its common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), having an aggregate
offering price of up to $11.70 million, from time to time through the Sales Agent as the Company&#8217;s sales agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Pursuant to the Sales Agreement,
sales of the shares of Common Stock (&#8220;Shares&#8221;), if any, will be made under the Company&#8217;s Registration Statement on Form
S-3 (File No. 333-282898), which was declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;) on November
6, 2024, and the related prospectus and prospectus supplement. The Company may sell the Shares in transactions that are deemed to be &#8220;at
the market offerings&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on or through
the Nasdaq Capital Market or any other trading market for the Common Stock. The Sales Agent is entitled to compensation of 3.0% of the
gross proceeds from the sales of any Shares pursuant to the Sales Agreement and will be reimbursed for certain expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Sales Agreement contains
customary representations, warranties, and covenants of the Company and the Agent, indemnification and contribution provisions, and conditions
precedent to the sale of the Shares pursuant to the Sales Agreement. The Company may terminate the Sales Agreement at any time upon ten
(10) days&#8217; notice to the Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company is not obligated
to sell any Shares under the Sales Agreement and may at any time suspend sales pursuant to the Sales Agreement upon notice to the Sales
Agent and subject to the terms of the Sales Agreement. The Sales Agreement may be terminated by either party at any time upon notice to
the other party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The foregoing description
of the Sales Agreement is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed as
Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">This Current Report on Form
8-K shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be
any offer, solicitation or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A copy of the opinion of
Dickinson Wright, PLLC relating to the validity of the Shares issued in the Offering is filed herewith as Exhibit 5.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Except for the historical
information contained herein, this document contains forward looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements regarding our strategy, plans, objectives and initiatives, including our expectations regarding
the future revenue growth potential of each of our subsidiaries, our expected timeline for commercializing our BE-Smart Esophageal Cancer
Test, our expectations regarding future liquidity events, the success of our efforts to collect accounts receivables and anticipated timeline
for any payments relating thereto, and our ability to successfully transition into a consumer products company. Management believes that
these forward-looking statements are reasonable as and when made. However, such forward-looking statements involve known and unknown risks,
uncertainties, and other factors that may cause actual results to differ materially from those projected in the forward-looking statements.
These risks and uncertainties include but are not limited to our ability to obtain and maintain necessary regulatory approvals, general
economic conditions, consumer demand for our products and services, challenges relating to entering into and growing new business lines,
the competitive environment, and the risk factors listed from time to time in our Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q and any other SEC filings. These forward-looking statements are subject to risks and uncertainties and actual results may differ
materially. Details about these risks and uncertainties can be found in our filings with the SEC. The Company undertakes no obligation
to update forward-looking statements except as required by applicable securities laws. Readers are cautioned that forward-looking statements
are not guarantees of future performance and are cautioned not to place undue reliance on any forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">This press release does not
constitute an offer to sell or the solicitation of an offer to buy any securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Item 9.01 Financial Statements
and Exhibits. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Exhibit Index</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td><span style="text-decoration: underline">Exhibit No</span>.</td>
<td><span style="text-decoration: underline">Description</span></td></tr>
<tr style="vertical-align: top">
<td style="width: 12%">1.1</td>
<td style="width: 88%"><a href="e7056_ex1-1.htm">At-the-Market Sales Agreement, dated December 2, 2025, by and between Lunai Bioworks, Inc. and Dawson James Securities, Inc.</a></td></tr>
<tr style="vertical-align: top">
<td>5.1</td>
<td><a href="e7056_ex5-1.htm">Opinion of <span style="font-family: Times New Roman, Times, Serif">&#160;</span>Dickinson Wright, PLLC</a></td></tr>
<tr style="vertical-align: top">
<td>23.1</td>
<td><a href="e7056_ex5-1.htm">Consent of <span style="font-family: Times New Roman, Times, Serif">&#160;</span>Dickinson Wright, PLLC (included in Exhibit 5.1)</a></td></tr>
<tr style="vertical-align: top">
<td>104</td>
<td>Cover Page Interactive Data File (embedded within the Inline XBRL
document).</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt; text-indent: -72pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>SIGN<span style="letter-spacing: -0.65pt">A</span>TURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 258.95pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 32.35pt">Pursuant to the requ<span style="letter-spacing: 0.05pt">i</span>rements
of the <span style="letter-spacing: 0.05pt">S</span>ecurities <span style="letter-spacing: 0.05pt">E</span>xchange Act of 1934, the registrant
h<span style="letter-spacing: 0.05pt">a</span>s duly caused this report to be signed on its behalf by <span style="letter-spacing: 0.05pt">t</span>he
undersigned hereunto duly authori<span style="letter-spacing: 0.05pt">z</span>ed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 32.35pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LUNAI BIOWORKS, INC.</b></span></td></tr>
<tr style="vertical-align: top">
<td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
<td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David Weinstein</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Weinstein</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">December 2, 2025</p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 32.35pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 32.35pt">&#160;</p>



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LG5WVNijQ4c4RYaIr8VFKW7NSOvcPsm/tNsQQyAk954bISYipa0ukeG6zjM4Y1WXyiHkeEdGc0PvSHb7GPzM8aGtY2XcsP7AhDyDnllO58rfB2ejLRYxzGQYyVAuIFrF8yWcDiLo9YTMXRdonFYlKFPAialmjU5xNyacVUuGqm74dEG2moyPm0aj/AEZzSQcqVFv4qeFLEtEMBkqECnTq/auTevQ9CRsSqz8OzvS/w6+zIBKXg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>e7056_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>EXHIBIT 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Lunai Bioworks
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>ATM SALES
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;December 2, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dawson James Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">101 North Federal Highway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Boca Raton, Fl 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Lunai Bioworks Inc., a Delaware
corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), confirms its agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) with Dawson
James Securities, Inc., as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
and Sale of Shares</U>. The Company agrees that, from time to time during the term of this Agreement as set forth below, on the terms
and subject to the conditions set forth herein, it may issue and sell to or through Dawson James Securities, Inc., acting as agent and/or
principal (the &ldquo;<B><U>Sales Agent</U></B>&rdquo;), shares of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B><U>Common
Stock</U></B>&rdquo;), subject to the limitations set forth in <U>Section 3(b)</U> hereof. The issuance and sale of the Common Stock to
or through the Sales Agent will be effected pursuant to the Registration Statement (as defined below) filed by the Company and which was
declared effective under the Securities Act (as defined below) by the U.S. Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The term of this Agreement shall
commence on the date on which the Registration Statement (as defined below) is declared effective by the Commission and shall end upon
the termination or expiration of this Agreement in accordance with <U>Section 11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">On the date of this Agreement,
the Company has filed, or will file, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations
thereunder (collectively, the &ldquo;<B><U>Securities Act</U></B>&rdquo;), with the Commission, a shelf registration statement on Form
S-3, including a base prospectus (the &ldquo;<B><U>Base Prospectus</U></B>&rdquo;), relating to certain securities, including the Common
Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will
file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively,
the &ldquo;<B><U>Exchange Act</U></B>&rdquo;). The Company has prepared a prospectus specifically relating to the offering of Common Stock
pursuant to this Agreement included as part of such registration statement (the &ldquo;<B><U>ATM Prospectus</U></B>&rdquo; and, together
with the Base Prospectus, collectively, the &ldquo;<B><U>Initial Prospectus</U></B>&rdquo;). As soon as practicable following the date
that such registration statement is declared effective, the Company will furnish to the Sales Agent, for use by the Sales Agent, copies
of the ATM Prospectus included as part of such registration statement, relating to the Placement Shares (as defined below). Except where
the context otherwise requires, such registration statement, as amended when it becomes effective, including all documents filed as part
thereof or incorporated by reference therein, and including any information contained in any prospectus subsequently filed with the Commission
pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b)
of the Securities Act, is herein called the &ldquo;<B><U>Registration Statement</U></B>.&rdquo; The Initial Prospectus, including all
documents incorporated therein by reference (to the extent such information has not been superseded or modified in accordance with Rule
412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), as may be supplemented from time to time by any additional
prospectus supplement, in the form in which such Base Prospectus and/or ATM Prospectus have most recently been filed by the Company with
the Commission pursuant to Rule 424(b) under the Securities Act, together with any &ldquo;issuer free writing prospectus&rdquo; (&ldquo;<B><U>Issuer
Free Writing Prospectus</U></B>&rdquo;), as defined in Rule 433 of the Securities Act (&ldquo;<B><U>Rule 433</U></B>&rdquo;), relating
to the Placement Shares that (i) is required to be filed with the Commission by the Company or (ii) is exempt from filing pursuant to
Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the
form retained in the Company&rsquo;s records pursuant to Rule 433(g), is herein called the &ldquo;<B><U>Prospectus</U></B>.&rdquo; Any
reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and
include the documents incorporated by reference therein, and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing
after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. For purposes of this Agreement,
all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any
copy filed with the Commission pursuant to either the Electronic Data Gathering Analysis and Retrieval System, or if applicable, the Interactive
Data Electronic Applications (collectively &ldquo;<B><U>EDGAR</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Placements</U>.
Each time that the Company wishes to issue and sell the Common Stock through the Sales Agent, as agent, hereunder (each, a &ldquo;<B><U>Placement</U></B>&rdquo;),
it will notify the Sales Agent by email notice (or other method mutually agreed to in writing by the parties) (a &ldquo;<B><U>Placement
Notice</U></B>&rdquo;) containing the parameters in accordance with which it desires the Common Stock to be sold, which shall at a minimum
include the number of shares of Common Stock to be issued (the &ldquo;<B><U>Placement Shares</U></B>&rdquo;), the time period during which
sales are requested to be made, any limitation on the number of shares of Common Stock that may be sold in any one Trading Day (as defined
in <U>Section 3</U>) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters
necessary is attached hereto as <B><U>Schedule 1</U></B>. The Placement Notice shall originate from any of the individuals from the Company
set forth on <B><U>Schedule 2</U></B> (with a copy to each of the other individuals from the Company listed on such schedule), and shall
be addressed to each of the individuals from the Sales Agent set forth on <B><U>Schedule 2</U></B>, as such <B><U>Schedule 2</U></B> may
be amended from time to time. The Placement Notice shall be effective upon receipt by the Sales Agent unless and until (i) in accordance
with the notice requirements set forth in <U>Section 4</U>, the Sales Agent declines to accept the terms contained therein for any reason,
in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements
set forth in <U>Section 4</U>, the Company suspends or terminates the Placement Notice, (iv) the Company issues a subsequent Placement
Notice with parameters superseding those on the earlier dated Placement Notice, or (v) the Agreement has been terminated under the provisions
of <U>Section 11</U>. The amount of any discount, commission or other compensation to be paid by the Company to the Sales Agent in connection
with the sale of the Placement Shares through the Sales Agent, as agent, shall be as set forth in <B><U>Schedule 3</U></B>. It is expressly
acknowledged and agreed that neither the Company nor the Sales Agent will have any obligation whatsoever with respect to a Placement or
any Placement Shares unless and until the Company delivers a Placement Notice to the Sales Agent and the Sales Agent does not decline
such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of
a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale
of Placement Shares by the Sales Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) Subject to the terms and conditions
herein set forth, upon the Company&rsquo;s issuance of a Placement Notice, and unless the sale of the Placement Shares described therein
has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Sales Agent, as agent for the
Company, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and
federal laws, rules and regulations and the rules of The Nasdaq Capital Market (the &ldquo;<B><U>Exchange</U></B>&rdquo;), for the period
specified in the Placement Notice, to sell such Placement Shares up to the amount specified by the Company in, and otherwise in accordance
with the terms of such Placement Notice. If acting as agent hereunder, the Sales Agent will provide written confirmation to the Company
(including by email correspondence to each of the individuals of the Company set forth on <B><U>Schedule 2</U></B>, if receipt of such
correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later than
the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares
hereunder setting forth the number of Placement Shares sold on such day, the volume-weighted average price of the Placement Shares, the
compensation payable by the Company to the Sales Agent pursuant to <U>Section 2</U> with respect to such sales, and the Net Proceeds (as
defined below) payable to the Company, with an itemization of the deductions made by the Sales Agent (as set forth in <U>Section 5(a)</U>)
from the gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice, the Sales Agent may sell Placement
Shares by any method permitted by law deemed to be an &ldquo;at the market&rdquo; offering as defined in Rule 415 under the Securities
Act, including without limitation sales made directly on the Exchange, on any other existing trading market for the Common Stock or to
or through a market maker. Subject to the terms of a Placement Notice, the Sales Agent may also sell Placement Shares by any other method
permitted by law, including but not limited to in negotiated transactions with the Company&rsquo;s prior written consent. The Company
acknowledges and agrees that (i) there can be no assurance that the Sales Agent will be successful in selling Placement Shares, (ii) the
Sales Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for
any reason other than a failure by the Sales Agent to use its commercially reasonable efforts consistent with its normal trading and sales
practices and applicable law and regulations to sell such Placement Shares as required under this Agreement and (iii)&nbsp;the Sales Agent
shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed
by the Sales Agent and the Company in writing and expressly set forth in a Placement Notice. For the purposes hereof, &ldquo;<B><U>Trading
Day</U></B>&rdquo; means any day on which shares of the Company&rsquo;s Common Stock are purchased and sold on the principal market on
which the shares of Common Stock are listed or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) Under no circumstances shall
the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the
aggregate number or gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser of: (i) the number
or dollar amount of Common Stock registered pursuant to the Registration Statement pursuant to which the offering hereunder is being made,
(ii) the number of authorized but unissued and unreserved Common Stock, (iii) the number or dollar amount of shares of Common Stock permitted
to be offered and sold by the Company under Form S-3 (including General Instruction I.B.6. of Form S-3, if and for so long as applicable),
(iv) the number or dollar amount of shares of Common Stock authorized from time to time to be issued and sold under this Agreement by
the Company&rsquo;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to
the Sales Agent in writing, or (v) the number or dollar amount of shares of Common Stock for which the Company has filed the ATM Prospectus
or other prospectus supplement specifically relating to the offering of the Placement Shares pursuant to this Agreement. Under no circumstances
shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum
price authorized from time to time by the Company&rsquo;s board of directors, a duly authorized committee thereof or a duly authorized
executive committee, and notified to the Sales Agent in writing. Notwithstanding anything to the contrary contained herein, the parties
hereto acknowledge and agree that compliance with the limitations set forth in this <U>Section 3(b)</U> on the number or dollar amount
of Placement Shares that may be issued and sold under this Agreement from time to time shall be the sole responsibility of the Company,
and that the Sales Agent shall have no obligation in connection with such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) During the term of this Agreement,
neither the Sales Agent nor any of its affiliates or subsidiaries shall engage in (i) any short sale of any security of the Company or
(ii) any sale of any security of the Company that the Sales Agent does not own or any sale which is consummated by the delivery of a security
of the Company borrowed by, or for the account of, the Sales Agent. During the term of this Agreement and notwithstanding anything to
the contrary herein, the Sales Agent agrees that in no event will the Sales Agent or its affiliates engage in any market making, bidding,
stabilization or other trading activity with regard to the Common Stock or related derivative securities if such activity would be prohibited
under Regulation M or other anti-manipulation rules under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Suspension
of Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) The Company or the Sales Agent
may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth
on <B><U>Schedule 2</U></B>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is
sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to
each of the individuals of the other party set forth on <B><U>Schedule 2</U></B>), suspend any sale of Placement Shares for a period of
time (a &ldquo;<B><U>Suspension Period</U></B>&rdquo;); <I>provided</I>, <I>however</I>, that such suspension shall not affect or impair
either party&rsquo;s obligations with respect to any Placement Shares sold hereunder prior to the receipt and acknowledgement of such
notice. Each of the parties agrees that no such notice under this <U>Section 4</U> shall be effective against the other unless it is made
to one of the individuals named on <B><U>Schedule 2</U></B> hereto, as such schedule may be amended from time to time. During a Suspension
Period, the Company shall not issue any Placement Notices and the Sales Agent shall not sell any Placement Shares hereunder. The party
that issued a suspension notice shall notify the other party in writing of the Trading Day on which the Suspension Period shall expire
not later than twenty-four (24) hours prior to such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) Notwithstanding any other provision
of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and the Sales
Agent agree that (i)&nbsp;no sale of Placement Shares will take place, (ii)&nbsp;the Company shall not request the sale of any Placement
Shares, and (iii)&nbsp;the Sales Agent shall not be obligated to sell or offer to sell any Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Settlement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) <U>Settlement of Placement
Shares</U>. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the
second (2<SUP>nd</SUP>) Trading Day (or such earlier day as is industry practice for regular-way trading) following the respective Point
of Sale (as defined below) (each, a &ldquo;<B><U>Settlement Date</U></B>&rdquo;). The amount of proceeds to be delivered to the Company
on a Settlement Date against receipt of the Placement Shares sold (the &ldquo;<B><U>Net Proceeds</U></B>&rdquo;) will be equal to the
aggregate sales price received by the Sales Agent at which such Placement Shares were sold, after deduction for (i) the Sales Agent&rsquo;s
discount, commission or other compensation for such sales payable by the Company pursuant to <U>Section 2</U> hereof, (ii) any other amounts
due and payable by the Company to the Sales Agent hereunder pursuant to Section 7(g) (Expenses) hereof and (iii) any transaction fees,
trading expenses or execution fees imposed by any clearing organization or any governmental or self-regulatory organization and any other
fees incurred by the Sales Agent in respect of such sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) <U>Delivery of Placement Shares</U>.
On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares
being sold by crediting the Sales Agent&rsquo;s or its designee&rsquo;s account (provided the Sales Agent shall have given the Company
written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian
System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable,
transferable, registered shares in good deliverable form. On each Settlement Date, the Sales Agent will deliver the related Net Proceeds
in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company,
or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Placement Shares on a Settlement Date, the
Company agrees that, in addition to and in no way limiting the rights and obligations set forth in <U>Section 9(a)</U> (Indemnification
and Contribution) hereto, the Company will (i) hold the Sales Agent, its directors, officers, members, partners, employees and agents
of the Sales Agent, each broker dealer affiliate of the Sales Agent, and each person, if any, who (A) controls the Sales Agent within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (B) is controlled by or is under common control with
the Sales Agent (each, a &ldquo;<B><U>Sales Agent Affiliate</U></B>&rdquo;), and the Sales Agent&rsquo;s clearing organization, harmless
against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection
with such default by the Company or its transfer agent (if applicable) and (ii) pay to the Sales Agent any commission, discount, or other
compensation to which it would otherwise have been entitled absent such default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company, on behalf of itself and its subsidiaries, represents and warrants to, and agrees with,
the Sales Agent that as of each Applicable Time (as defined in <U>Section 22(a)</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) <U>Compliance with Registration
Requirements</U>. As of each Applicable Time other than the date of this Agreement, the Registration Statement and any Rule 462(b) Registration
Statement have been declared effective by the Commission under the Securities Act. As of each Applicable Time other than the date of this
Agreement, the Company has not received from the Commission any notice pursuant to Rule 401(g)(1) under the Securities Act objecting to
the use of the shelf registration statement form. At the time of the initial filing of the Registration Statement, the Company paid (or
will pay) the required Commission filing fees relating to the Placement Shares in accordance with Rules 456(a) and 457(o) under the Securities
Act. The Company has complied to the Commission&rsquo;s satisfaction with all requests of the Commission for additional or supplemental
information related to the Registration Statement and the Prospectus. No stop order suspending the effectiveness of the Registration Statement
or any Rule 462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to
the best knowledge of the Company, are contemplated or threatened by the Commission. At the time of (i) the initial filing of the Registration
Statement with the Commission and (ii) the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities
Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange
Act or form of prospectus), the Company met the then applicable requirements for use of Form S-3 under the Securities Act, including compliance
with General Instructions I.A and I.B.6. of Form S-3, if and for so long as applicable. The Registration Statement and the offer and sale
of the Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects
with said Rule. In the section entitled &ldquo;Plan of Distribution&rdquo; in the ATM Prospectus, the Company has named Dawson James Securities,
Inc. as an agent that the Company has engaged in connection with the transactions contemplated by this Agreement. The Company was not
and is not an &ldquo;ineligible issuer&rdquo; as defined in Rule 405 under the Securities Act. The sale of the Placement Shares hereunder
meets the requirements of General Instruction I.B.1 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) <U>No Misstatement or Omission</U>.
The Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective, complied or will comply
in all material respects with the Securities Act. The Prospectus, and any amendment or supplement thereto, on the date of such Prospectus
or amendment or supplement, complied or will comply in all material respects with the Securities Act. The Registration Statement and any
post-effective amendment thereto, at the time it became or becomes effective, did not and will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus,
as amended or supplemented, as of its date, did not and, as of each Point of Sale and each Settlement Date, will not contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding sentences do
not apply to statements in or omissions from the Registration Statement or any post-effective amendment thereto, or the Prospectus, or
any amendments or supplements thereto, made in reliance upon and in conformity with information relating to the Sales Agent furnished
to the Company in writing by the Sales Agent expressly for use therein. &ldquo;<B><U>Point of Sale</U></B>&rdquo; means, for a Placement,
the time at which an acquiror of Placement Shares entered into a contract, binding upon such acquiror, to acquire such Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) <U>Offering Materials Furnished
to the Sales Agent</U>. Copies of the Registration Statement, the Prospectus, and all amendments or supplements thereto and all documents
incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement, have been delivered,
or are publicly available through EDGAR, to the Sales Agent. Each Prospectus delivered to the Sales Agent for use in connection with the
sale of the Placement Shares pursuant to this Agreement will be identical to the version of such Prospectus filed with the Commission
via EDGAR, except to the extent permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) <U>Distribution of Offering
Material By the Company</U>. The Company has not distributed and will not distribute, prior to the completion of the Sales Agent&rsquo;s
distribution of the Placement Shares, any offering material in connection with the offering and sale of the Placement Shares other than
the Prospectus or the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(e) <U>The Sales Agreement</U>.
This Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal, and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as rights to indemnity hereunder may be limited by
federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting the rights of creditors generally, and subject to general principles of equity. The Company has full corporate
power and authority to enter into this Agreement and to authorize, issue and sell the Placement Shares as contemplated by this Agreement.
This Agreement conforms in all material respects to the descriptions thereof in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(f) <U>Authorization of the Placement
Shares</U>. The Placement Shares, when issued and paid for as contemplated herein, will be validly issued, fully paid and nonassessable,
will be issued in compliance with all applicable securities laws, and will be free of preemptive, registration or similar rights, and
will conform to the description of the Common Stock contained in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(g) <U>No Applicable Registration
or Other Similar Rights</U>. There are no persons with registration or other similar rights to have any equity or debt securities registered
for sale under the Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been
duly waived. No person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and
sale of the Placement Shares hereunder, whether as a result of the filing or effectiveness of the Registration Statement or the sale of
the Placement Shares as contemplated hereby or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(h) <U>No Material Adverse Change</U>.
Except as otherwise disclosed in the Prospectus, subsequent to the respective dates as of which information is given in the Prospectus:
(i) there has been no material adverse change in the business, properties, prospects, operations, condition (financial or otherwise) or
results of operations of the Company and its subsidiaries, taken as a whole (any such change is called a &ldquo;<B><U>Material Adverse
Change</U></B>&rdquo;), or any development involving a prospective material adverse change, which, individually or in the aggregate, has
had or would reasonably be expected to result in a Material Adverse Change; (ii) the Company and its subsidiaries, considered as one entity,
have not incurred any material liability or obligation, indirect, direct or contingent, not in the ordinary course of business nor entered
into any material transaction or agreement not in the ordinary course of business; (iii) there has been no dividend or distribution of
any kind declared, paid or made by the Company or, except for regular quarterly dividends publicly announced by the Company or dividends
paid to the Company or other subsidiaries, by any of its subsidiaries on any class of capital stock or repurchase or redemption by the
Company or any of its subsidiaries of any class of capital stock; (iv) no officer or director of the Company has resigned from any position
with the Company; and (v) there has not been any Material Adverse Change in the Company&rsquo;s long-term debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(i) <U>Independent Accountants</U>.
To the knowledge of the Company, Sadler, Gibb &amp; Associates, LLC, whose report is filed with the Commission and included or incorporated
by reference in the Registration Statement and the Prospectus, is an independent registered public accounting firm as required by the
Securities Act and the Public Company Accounting Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(j) <U>Financial Statements</U>.
The financial statements incorporated by reference in the Registration Statement and in the Prospectus, together with the related notes
and schedules, comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, and fairly
present the consolidated financial position of the Company and its subsidiaries as of and at the dates indicated and the results of their
operations and cash flows for the periods therein specified. Such financial statements and supporting schedules have been prepared in
conformity with U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;) applied on a consistent basis throughout the
periods involved. No other financial statements, pro forma financial information or schedules are required under the Securities Act or
the Exchange Act to be included in or incorporated by reference in the Registration Statement or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(k) <U>Forward-Looking Statements</U>.
The Company had a reasonable basis for, and made in good faith, each &ldquo;forward-looking statement&rdquo; (within the meaning of Section
27A of the Securities Act or Section 21E of the Exchange Act) contained or incorporated by reference in the Registration Statement or
the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(l) <U>Statistical and Marketing-Related
Data</U>. All statistical or market-related data included or incorporated by reference in the Registration Statement or the Prospectus
are based on or derived from sources that the Company reasonably believes to be reliable and accurate, and, to the Company&rsquo;s knowledge,
the Company has obtained the written consent to the use of such data from such sources to the extent required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(m) <U>XBRL</U>. The interactive
data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the
information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(n) <U>Incorporation and Good Standing
of the Company and its Subsidiaries</U>. The Company is a corporation duly incorporated and validly existing under the laws of the State
of Delaware and in good standing under such laws. The Company has requisite corporate power to carry on its business as described in the
Prospectus. The Company is duly qualified to transact business and is in good standing in all jurisdictions in which the conduct of its
business requires such qualification; except where the failure to be so qualified or to be in good standing would not result in a Material
Adverse Change. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the
subsidiaries listed on Exhibit 21.1 to the Company&rsquo;s Annual Report on Form 10-K for the most recently ended fiscal year and other
than (i) those subsidiaries not required to be listed on Exhibit 21.1 by Item 601 of Regulation S-K under the Exchange Act, and (ii) as
disclosed in the Registration Statement and the Prospectus. Each subsidiary is a corporation or limited liability company duly incorporated
or formed and validly existing under the laws of the jurisdiction of its incorporation or formation and is in good standing under such
laws. Each of the subsidiaries has requisite corporate power to carry on its business as described in the Prospectus. Each of the subsidiaries
is duly qualified to transact business and is in good standing in all jurisdictions in which the conduct of its business requires such
qualification; except where the failure to be so qualified or to be in good standing would not result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(o) <U>Capital Stock Matters</U>.
The Company has an authorized capitalization as set forth in the Registration Statement and the Prospectus. The form of certificates for
the Common Stock conforms to the corporate law of the jurisdiction of the Company&rsquo;s incorporation. All of the issued and outstanding
shares of capital stock of the Company are duly authorized and validly issued, fully paid and nonassessable, and have been issued in compliance
with all applicable securities laws, and conform to the description thereof in the Registration Statement and the Prospectus. None of
the outstanding shares of capital stock of the Company were issued in violation of any preemptive rights, rights of first refusal or other
similar rights to subscribe for or purchase securities of the Company. All of the issued shares of capital stock of each subsidiary of
the Company have been duly and validly authorized and issued, are fully paid and nonassessable and, except as set forth in the Registration
Statement and the Prospectus, are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or
claims. Except for the issuances of options or restricted stock pursuant to the Company&rsquo;s incentive plans or as otherwise set forth
in the Registration Statement and the Prospectus, since the respective dates as of which information is provided in the Registration Statement
or the Prospectus, the Company has not entered into or granted any convertible or exchangeable securities, options, warrants, agreements,
contracts or other rights in existence to purchase or acquire from the Company any shares of the capital stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(p) <U>Non-Contravention of Existing
Instruments; No Further Authorizations or Approvals Required</U>. The Company&rsquo;s execution, delivery and performance of this Agreement
and consummation of the transactions contemplated hereby or by the Registration Statement and the Prospectus (including the issuance and
sale of the Placement Shares and the use of the proceeds from the sale of the Placement Shares as described in the Prospectus under the
caption &ldquo;Use of Proceeds&rdquo;) will not (A) result in a breach or violation of any of the terms and provisions of, or constitute
a default under, any law, order, rule or regulation to which the Company or any subsidiary is subject, or by which any property or asset
of the Company or any subsidiary is bound or affected, (B)&nbsp;conflict with, result in any violation or breach of, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) (a &ldquo;<B><U>Default Acceleration Event</U></B>&rdquo;)
of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (&ldquo;<B><U>Contract</U></B>&rdquo;)
or obligation or other understanding to which the Company or any subsidiary is a party or by which any property or asset of the Company
or any subsidiary is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event is not reasonably
likely to result in a Material Adverse Change, or (C) result in a breach or violation of any of the terms and provisions of, or constitute
a default under, the Company&rsquo;s certificate of incorporation or bylaws. Except as set forth in the Registration Statement and the
Prospectus, neither the Company nor any of its subsidiaries is in violation, breach or default under its Certificate of Incorporation,
bylaws or other equivalent organizational or governing documents. Neither the Company nor any its subsidiaries nor, to its knowledge,
any other party is in violation, breach or default of any Contract that has resulted in or could reasonably be expected to result in a
Material Adverse Change. Each approval, consent, order, authorization, designation, declaration or filing by or with any regulatory, administrative
or other governmental body necessary in connection with the execution and delivery by the Company of this Agreement and the performance
of the Company of the transactions herein contemplated has been obtained or made and is in full force and effect, except (i) with respect
to any Applicable Time at which the Sales Agent would not be able to rely on Rule 5110(h)(1)(C) of the Financial Industry Regulatory Authority,
Inc. (&ldquo;<B><U>FINRA</U></B>&rdquo;), such additional steps as may be required by FINRA, (ii) filings with the Commission required
under the Securities Act or the Exchange Act, or filings with the Exchange pursuant to the rules and regulations of the Exchange, in each
case that are contemplated by this Agreement to be made after the date of this Agreement, and (iii) such additional steps as may be necessary
to qualify the Common Stock for sale by the Sales Agent under state securities or Blue Sky laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(q) <U>No Material Actions or Proceedings</U>.
Except as set forth in the Registration Statement and the Prospectus, there is not pending or, to the knowledge of the Company, threatened,
any action, suit or proceeding to which the Company or any of its subsidiaries is a party or of which any property or assets of the Company
or any of its subsidiaries is the subject before or by any court or governmental agency, authority or body, or any arbitrator or mediator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(r) <U>Labor Disputes</U>. There
is (A) no unfair labor practice complaint pending against the Company, or any of its subsidiaries, nor to the Company&rsquo;s knowledge,
threatened against it or any of its subsidiaries, before the National Labor Relations Board, any state or local labor relation board or
any foreign labor relations board, and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement
is so pending against the Company or any of its subsidiaries, or, to the Company&rsquo;s knowledge, threatened against it and (B) no labor
disturbance by the employees of the Company or any of its subsidiaries exists or, to the Company&rsquo;s knowledge, is imminent, and the
Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries, principal suppliers,
manufacturers, customers or contractors, that could reasonably be expected, singularly or in the aggregate, to have a Material Adverse
Change. The Company is not aware that any key employee or significant group of employees of the Company or any subsidiary plans to terminate
employment with the Company or any such subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(s) <U>All Necessary Permits, etc</U>.
Except as set forth in the Registration Statement and the Prospectus, the Company and each of its subsidiaries holds, and is in compliance
with, all franchises, grants, authorizations, licenses, permits, easements, consents, certificates and orders (&ldquo;<B><U>Permits</U></B>&rdquo;)
of any governmental or self-regulatory agency, authority or body required for the conduct of its business, and all such Permits are in
full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(t) <U>Tax Law Compliance</U>.
Other than as disclosed in the Registration Statement Package and the Prospectus, each of the Company and its subsidiaries has (a) filed
all foreign, federal, state and local tax returns (as hereinafter defined) required to be filed with taxing authorities prior to the date
hereof or has duly obtained extensions of time for the filing thereof and (b) paid all taxes (as hereinafter defined) shown as due and
payable on such returns that were filed and has paid all taxes imposed on or assessed against the Company or such respective subsidiary.
The provisions for taxes payable, if any, shown on the financial statements included or incorporated by reference in the Registration
Statement and the Prospectus are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including
the dates of such consolidated financial statements. Other than as disclosed in the Registration Statement and the Prospectus, no issues
have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from
the Company or its subsidiaries, and no waivers of statutes of limitation with respect to the returns or collection of taxes have been
given by or requested from the Company or its subsidiaries. There are no tax liens against the assets, properties or business of the Company
or any of its subsidiaries. The term &ldquo;<B><U>taxes</U></B>&rdquo; mean all federal, state, local, foreign, and other net income,
gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding,
payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees,
assessments, or charges of any kind whatever, together with any interest and any penalties, additions to tax, or additional amounts with
respect thereto. The term &ldquo;<B><U>returns</U></B>&rdquo; means all returns, declarations, reports, statements, and other documents
required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(u) <U>Company Not an &ldquo;Investment
Company</U>&rdquo;. The Company is not, and will not be, either after receipt of payment for the Placement Shares or after the application
of the proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement or the Prospectus, required to
register as an &ldquo;investment company&rdquo; under the Investment Company Act of 1940, as amended (the <B>&ldquo;<U>Investment Company
Act</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(v) <U>Insurance</U>. The Company
and each of its subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as is adequate for the conduct
of its business and the value of its properties and as is customary for companies engaged in similar businesses in similar industries,
and all such insurance is in full force and effect. Neither the Company nor any of its subsidiaries has reason to believe that it will
not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material
Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(w) <U>No Price Stabilization or
Manipulation</U>. Neither the Company nor any of its subsidiaries has taken, directly or indirectly (without giving any effect to the
activities of the Agent), any action designed to or that might cause or result in stabilization or manipulation of the price of the Common
Stock or of any &ldquo;reference security&rdquo; (as defined in Rule 100 of Regulation M under the Exchange Act (&ldquo;<B><U>Regulation
M</U></B>&rdquo;)) with respect to the Common Stock, whether to facilitate the sale or resale of the Placement Shares or otherwise, and
has taken no action which would directly or indirectly violate Regulation M.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(x) <U>Related Party Transactions</U>.
There are no business relationships or related party transactions involving the Company, any of its subsidiaries, or any other person
required to be described in the Registration Statement and the Prospectus that have not been described as required pursuant to the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(y) <U>Exchange Act Compliance</U>.
The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Prospectus or any amendment or
supplement thereto, at the time they were or hereafter are filed with the Commission under the Exchange Act, complied and will comply
in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Prospectus,
at each Point of Sale and each Settlement Date, will not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(z) <U>Conformity of Issuer Free
Writing Prospectus</U>. Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of
the Securities Act on the date of first use, and the Company has complied or will comply with any filing requirements applicable to such
Issuer Free Writing Prospectus pursuant to the Securities Act. Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent
times through the completion of the public offer and sale of the Placement Shares, did not, does not and will not include any information
that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including
any document incorporated by reference therein that has not been superseded or modified. The Company has not made any offer relating to
the Placement Shares that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Sales Agent. The
Company has retained in accordance with the Securities Act all Issuer Free Writing Prospectuses that were not required to be filed pursuant
to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(aa) <U>Compliance with Environmental
Laws</U>. The Company and its subsidiaries are in compliance with all foreign, federal, state and local rules, laws and regulations relating
to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment
which are applicable to their businesses (&ldquo;<B><U>Environmental Laws</U></B>&rdquo;), except where the failure to comply has not
had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Change. There has been no storage,
generation, transportation, handling, treatment, disposal, discharge, emission, or other release of any kind of toxic or other wastes
or other hazardous substances by, due to, or caused by the Company or any of its subsidiaries (or, to the Company&rsquo;s knowledge, any
other entity for whose acts or omissions the Company or any of its subsidiaries is or may otherwise be liable) upon any of the property
now or previously owned or leased by the Company or any of its subsidiaries, or upon any other property, in violation of any law, statute,
ordinance, rule, regulation, order, judgment, decree or permit or which would, under any law, statute, ordinance, rule (including rule
of common law), regulation, order, judgment, decree or permit, give rise to any liability, except for any violation or liability which
has not had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Change; and there has been
no disposal, discharge, emission or other release of any kind onto such property or into the environment surrounding such property of
any toxic or other wastes or other hazardous substances with respect to which the Company or any of its subsidiaries has knowledge. The
Company and its subsidiaries have reviewed the effect of Environmental Laws on their business and assets, in the course of which they
identified and evaluated associated costs and liabilities (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws or governmental permits issued thereunder, any related constraints
on operating activities and any potential liabilities to third parties). On the basis of such review, the Company has reasonably concluded
that such associated costs and liabilities would not have, singularly or in the aggregate, a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(bb) <U>Intellectual Property</U>.
The Company and each of its subsidiaries own or possess or have valid rights to use all patents, patent applications, trademarks, service
marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights
(&ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;) necessary for the conduct of the business of the Company and its subsidiaries
as currently carried on and as described in the Registration Statement and the Prospectus, except as would not be reasonably likely to
result in a Material Adverse Change. To the knowledge of the Company, no action or use by the Company or any of its subsidiaries necessary
for the conduct of their business as currently carried on and as described in the Registration Statement and the Prospectus will involve
or give rise to any infringement of, or license or similar fees for, any Intellectual Property Rights of others, except where such action,
use, license or fee is not reasonably likely to result in a Material Adverse Change. Neither the Company nor any of its subsidiaries have
received any notice alleging any such infringement,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">fee or conflict with asserted Intellectual Property Rights of others. Except as would
not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company,
there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company
or any of its subsidiaries; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim
by others challenging the rights of the Company or any of its subsidiaries in or to any such Intellectual Property Rights, and the Company
is unaware of any facts which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together
with any other claims in this <U>Section 6(bb)</U>, reasonably be expected to result in a Material Adverse Change; (C) the Intellectual
Property Rights owned by the Company or any of its subsidiaries and, to the knowledge of the Company, the Intellectual Property Rights
licensed to the Company have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole or in part, and
there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity
or scope of any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any
such claim that would, individually or in the aggregate, together with any other claims in this <U>Section 6(bb)</U>, reasonably be expected
to result in a Material Adverse Change; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding
or claim by others that the Company or any of its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property
Rights or other proprietary rights of others, neither the Company nor any of its subsidiaries has received any written notice of such
claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or
in the aggregate, together with any other claims in this <U>Section 6(bb)</U>, reasonably be expected to result in a Material Adverse
Change; and (E) except as disclosed in the Registration Statement and the Prospectus, to the Company&rsquo;s knowledge, no employee of
the Company or any of its subsidiaries is in or has ever been in violation in any material respect of any term of any employment contract,
patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement
or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment
with the Company or any of its subsidiaries, or actions undertaken by the employee while employed with the Company or any of its subsidiaries
and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge,
all material technical information developed by and belonging to the Company or any of its subsidiaries which has not been patented has
been kept confidential. Neither the Company nor any of its subsidiaries is a party to or bound by any options, licenses or agreements
with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration Statement
and the Prospectus and are not described therein. The Registration Statement and the Prospectus contain in all material respects the same
description of the matters set forth in the preceding sentence. None of the technology employed by the Company or its subsidiaries has
been obtained or is being used by the Company or any of its subsidiaries in violation of any contractual obligation binding on the Company
or any such subsidiary or, to the Company&rsquo;s knowledge, any of its or its subsidiaries&rsquo; officers, directors or employees, or
otherwise in violation of the rights of any persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(cc) <U>Brokers</U>. Neither the
Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than as contemplated
by this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or the Sales Agent for a brokerage
commission, finder&rsquo;s fee or like payment in connection with the offering and sale of the Placement Shares by the Sales Agent under
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(dd) <U>No Outstanding Loans or
Other Indebtedness</U>. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course
of business) or guarantees or indebtedness by the Company or any of its subsidiaries to or for the benefit of any of the officers or directors
of the Company or executive officers of any of its subsidiaries to the extent such executive officers may be deemed executive officers
of the Company, or any of their respective family members, except as disclosed in the Registration Statement and the Prospectus. The Company
has not directly or indirectly extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit,
in the form of a personal loan to or for any director or executive officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ee) <U>No Reliance</U>. The Company
has not relied upon the Sales Agent or legal counsel for the Sales Agent for any legal, tax or accounting advice in connection with the
offering and sale of the Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ff) <U>Broker-Dealer Status</U>.
Neither the Company nor any of its related entities (i) is required to register as a &ldquo;broker&rdquo; or &ldquo;dealer&rdquo; in accordance
with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a &ldquo;person
associated with a member&rdquo; or &ldquo;associated person of a member&rdquo; (within the meaning of Article I of the NASD Manual administered
by FINRA). To the Company&rsquo;s knowledge, there are no affiliations or associations between any member of FINRA and any of the Company&rsquo;s
officers, directors or 10% or greater security holders, except as set forth in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(gg). <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(hh) <U>FINRA Matters</U>. All
of the information provided to the Sales Agent or to counsel for the Sales Agent by the Company, its counsel, its officers and directors
and, to the Company&rsquo;s knowledge, the holders of any securities (debt or equity) or options to acquire any securities of the Company
in connection with the offering of the Placement Shares is true, complete, correct and compliant with FINRA&rsquo;s rules in all material
respects and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or NASD Conduct Rules is
true, complete and correct in all material respects. Except as disclosed in the Registration Statement and the Prospectus, there is no
(i) officer or director of the Company, (ii) beneficial owner of 10% or more of any class of the Company&rsquo;s securities or (iii) beneficial
owner of the Company&rsquo;s unregistered equity securities that were acquired during the 180-day period immediately preceding the date
of this Agreement that is an affiliate or associated person of a FINRA member participating in the offer, issuance and sale of the Placement
Shares as contemplated by this Agreement and the Registration Statement and the Prospectus (as determined in accordance with the rules
and regulations of FINRA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ii) <U>Compliance with Orders</U>.
Neither the Company nor any of its subsidiaries is in violation of any material judgment, decree, or order of any court, arbitrator or
other governmental authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(jj) <U>Compliance with Certain
Applicable Laws</U>. The Company and each of its subsidiaries: (A) is and at all times has been in compliance with all statutes, rules,
or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling,
promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company (&ldquo;<B><U>Applicable
Laws</U></B>&rdquo;), except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change;
(B) has not received any warning letter, untitled letter or other correspondence or notice from any governmental authority alleging or
asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements
or amendments thereto required by any such Applicable Laws (&ldquo;<B><U>Authorizations</U></B>&rdquo;); (C) possesses all material Authorizations
and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations;
(D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from
any governmental authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations
and has no knowledge that any such governmental authority or third party is considering any such claim, litigation, arbitration, action,
suit, investigation or proceeding; (E) has not received notice that any governmental authority has taken, is taking or intends to take
action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering
such action; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records,
claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents,
forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or
were corrected or supplemented by a subsequent submission).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(kk) <U>Sarbanes&ndash;Oxley Act</U>.
There is and has been no failure on the part of the Company or any of the Company&rsquo;s directors or officers, in their capacities as
such, to comply in all material respects with any applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith (the &ldquo;<B><U>Sarbanes-Oxley Act</U></B>&rdquo;), including Section 402 related to loans and Sections
302 and 906 related to certifications..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ll) <U>Disclosure Controls And
Procedures</U>. Except as set forth in the Registration Statement and the Prospectus, the Company and its subsidiaries maintain systems
of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules 13a-15 and 15d-15 under the Exchange Act) that comply
with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive
and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited
to, internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with
management&rsquo;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language
included or incorporated by references in the Registration Statement and the Prospectus fairly present the information called for in all
material respects and are prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto. Since the date of
the latest audited financial statements included in the Registration Statement and the Prospectus, there has been no change in the Company&rsquo;s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(mm) <U>ERISA</U>. The Company,
its subsidiaries and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security Act of 1974, as
amended, and the regulations and published interpretations thereunder (collectively, &ldquo;<B><U>ERISA</U></B>&rdquo;)) established or
maintained by the Company, its subsidiaries or any of their &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all
material respects with ERISA. &ldquo;<B><U>ERISA Affiliate</U></B>&rdquo; means, with respect to the Company and each of its subsidiaries,
any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended,
and the regulations and published interpretations thereunder (the &ldquo;<B><U>Code</U></B>&rdquo;) of which the Company or any of its
subsidiaries is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected to occur with
respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company, or any of its subsidiaries or any of their
ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company, any of its subsidiaries or any of their
ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
(as defined under ERISA). Neither the Company nor any of its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably
expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee
benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained
by the Company, any of its subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the
Code is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause
the loss of such qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(nn) <U>Contracts and Agreements</U>.
The agreements and documents described in the Registration Statement and the Prospectus conform in all material respects to the descriptions
thereof contained therein and there are no agreements or other documents required by the Securities Act to be described in the Registration
Statement and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described
or filed. Each agreement or other instrument (however characterized or described) to which the Company or any of its subsidiaries is a
party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement and the Prospectus, or (ii)
is material to the Company&rsquo;s or its subsidiaries&rsquo; business, has been duly authorized and validly executed by the Company,
is in full force and effect in all material respects and is enforceable against the Company or any of its subsidiaries and, to the Company&rsquo;s
knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution
provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and
other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought. Except as disclosed in the Registration Statement and the Prospectus, none of such agreements or instruments
has been assigned by the Company or its subsidiaries, and neither the Company, its subsidiaries nor, to the Company&rsquo;s knowledge,
any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or
the giving of notice, or both, would constitute a default thereunder. To the best of the Company&rsquo;s knowledge, performance by the
Company or any of its subsidiaries of the material provisions of such agreements or instruments will not result in a violation of any
existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having
jurisdiction over the Company, its subsidiaries or any of their assets or businesses (each, a &ldquo;<B><U>Governmental Entity</U></B>&rdquo;),
including, without limitation, those relating to environmental laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(oo) <U>Title to Properties</U>.
Except as set forth in the Registration Statement and the Prospectus, the Company and each of its subsidiaries have good and marketable
title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property which are material to the
business of the Company, in each case free and clear of all liens, encumbrances, security interests, claims and defects that do not, singly
or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made of such
property by the Company or any of its subsidiaries; and all of the leases and subleases material to the business of the Company, and under
which the Company or any of its subsidiaries hold properties described in the Registration Statement and the Prospectus, are in full force
and effect, and neither the Company nor any of its subsidiaries has received any notice of any material claim of any sort that has been
asserted by anyone adverse to the rights of the Company or any of its subsidiaries under any of the leases or subleases mentioned above,
or affecting or questioning the rights of the Company or any of its subsidiaries to the continued possession of the leased or subleased
premises under any such lease or sublease, which would result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(pp) <U>No Unlawful Contributions
or Other Payments</U>. No payments or inducements have been made or given, directly or indirectly, to any federal or local official or
candidate for, any federal or state office in the United States or foreign offices by the Company, any of its subsidiaries or any of their
officers or directors, or, to the knowledge of the Company, by any of its employees or agents or any other person in connection with any
opportunity, contract, permit, certificate, consent, order, approval, waiver or other authorization relating to the business of the Company
or any of its subsidiaries, except for such payments or inducements as were lawful under applicable laws, rules and regulations. Neither
the Company, any of its subsidiaries, nor, to the knowledge of the Company, any director, officer, agent, employee or other person associated
with or acting on behalf of the Company or any of its subsidiaries, (i) has used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any government
official or employee from corporate funds; or (iii) made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful
payment in connection with the business of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(qq) <U>Foreign Corrupt Practices
Act</U>. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate
or other person acting on behalf of the Company or any of its subsidiaries, is aware of or has taken any action, directly or indirectly,
that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations
thereunder (collectively, the &ldquo;<B><U>FCPA</U></B>&rdquo;), including, without limitation, making use of the mails or any means or
instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of
any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &ldquo;foreign official&rdquo;
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office,
in contravention of the FCPA. The Company and its subsidiaries have conducted their respective businesses in compliance with the FCPA
and have instituted and maintains policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(rr) <U>Money Laundering Laws</U>.
The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of
all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the &ldquo;<B><U>Money Laundering Laws</U></B>&rdquo;) and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ss) <U>OFAC</U>. None of the Company,
any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or person acting on behalf
of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;); and the Company will not directly or indirectly use the proceeds of
the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(tt) <U>Exchange Listing</U>. The
Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is currently listed on the Exchange under the trading symbol
&ldquo;GCTK&rdquo;. Except as disclosed in the Registration Statement and the Prospectus, there is no action pending by the Company or,
to the Company&rsquo;s knowledge, the Exchange to delist the Common Stock from the Exchange, nor has the Company received any notification
that the Exchange is contemplating terminating such listing. The Company has no intention to delist the Common Stock from the Exchange
or to deregister the Common Stock under the Exchange Act, in either case, at any time during the period commencing on the date of this
Agreement through and including the 90th calendar day after the termination of this Agreement. The Placement Shares have been approved
for listing on the Exchange. The issuance and sale of the Placement Shares under this Agreement does not contravene the rules and regulations
of the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(uu) <U>Margin Rules</U>. The Company
owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of Governors of the Federal Reserve System
(the &ldquo;<B><U>Federal Reserve Board</U></B>&rdquo;), and none of the proceeds from the issuance, sale and delivery of the Placement
Shares as contemplated by this Agreement and as described in the Registration Statement and the Prospectus will be used, directly or indirectly,
for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally
incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of Common Stock to be considered
a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(vv) <U>Underwriter Agreements</U>.
The Company is not a party to any agreement with an agent or underwriter for any other &ldquo;at-the-market&rdquo; or continuous equity
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ww) <U>Board of Directors</U>.
The qualifications of the persons serving as board members of the Company and the overall composition of the Company&rsquo;s Board of
Directors comply with the applicable requirements of the Exchange Act and the Sarbanes-Oxley Act and the listing rules of the Exchange
applicable to the Company. At least one member of the Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit
committee financial expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at
least a majority of the persons serving on the Board of Directors of the Company qualify as &ldquo;independent,&rdquo; as defined under
the listing rules of the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(xx) <U>No Integration</U>. Neither
the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause the offer and sale of the Placement
Shares hereunder to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration
of any such securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(yy) <U>No Material Defaults</U>.
Neither the Company nor any of its subsidiaries has defaulted on any installment on indebtedness for borrowed money or on any rental on
one or more long-term leases, which defaults, individually or in the aggregate, could reasonably be expected to result in a Material Adverse
Change. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual
Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has
defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually
or in the aggregate, could reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(zz) <U>Books and Records</U>.
The minute books of the Company and each of its subsidiaries have been made available to the Sales Agent and counsel for the Sales Agent,
and such books (i) contain a substantially complete summary of all meetings and material actions of the board of directors (including
each board committee) and stockholders of the Company (or analogous governing bodies and interest holders, as applicable) and each of
its subsidiaries since the time of its respective incorporation or organization through the date of the latest meeting and action, and
(ii) accurately in all material respects reflect all transactions referred to in such minutes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(aaa) <U>Continued Business</U>.
No supplier, customer, distributor or sales agent of the Company or any subsidiary has notified the Company or any subsidiary that it
intends to discontinue or decrease the rate of business done with the Company or any subsidiary, except where such discontinuation or
decrease has not resulted in and could not reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(bbb) <U>Regulations</U>. The disclosures
in the Registration Statement and the Prospectus concerning the effects of federal, state, local and all foreign regulation on the Company&rsquo;s
business in the past and as currently contemplated are correct in all material respects and no other such regulations are required to
be disclosed in the Registration Statement and the Prospectus which are not so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ccc) <U>Confidentiality and Non-Competitions</U>.
To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the Company or any of its subsidiaries is subject
to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer or prior employer that
could reasonably be expected to materially affect his or her ability to be and act in his or her respective capacity for the Company or
to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(ddd) <U>Dividend Restrictions</U>.
<FONT STYLE="background-color: white">Except as described in the Registration Statement and the Prospectus, no subsidiary of the Company
is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with
respect to such subsidiary&rsquo;s equity securities or from repaying to the Company or any other subsidiary of the Company any amounts
that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring any property
or assets to the Company or to any other subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any certificate signed by an officer of the Company
and delivered to the Sales Agent or to counsel for the Sales Agent pursuant to or in connection with this Agreement shall be deemed to
be a representation and warranty by the Company to the Sales Agent as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company acknowledges that the Sales Agent and,
for purposes of the opinions to be delivered pursuant to <U>Section 7</U> hereof, counsel to the Company and counsel to the Sales Agent,
will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants
of the Company</U>. The Company covenants and agrees with the Sales Agent that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) <U>Registration Statement Amendments</U>.
After the date of this Agreement and during any period in which a Prospectus relating to any Placement Shares is required to be delivered
by the Sales Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 153 or
Rule&nbsp;172 under the Securities Act), (i) the Company will notify the Sales Agent promptly of the time when any subsequent amendment
to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective
or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to
the Registration Statement or Prospectus or for additional information; (ii) the Company will prepare and file with the Commission, promptly
upon the Sales Agent&rsquo;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in the
Sales Agent&rsquo;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by the
Sales Agent (<I>provided</I>, <I>however</I>, that the failure of the Sales Agent to make such request shall not relieve the Company of
any obligation or liability hereunder, or affect the Sales Agent&rsquo;s right to rely on the representations and warranties made by the
Company in this Agreement, and <I>provided</I>, <I>further</I>, that the only remedy the Sales Agent shall have with respect to the failure
to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the Company
will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference,
relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to the Sales
Agent within a reasonable period of time before the filing and the Sales Agent has not reasonably objected thereto (<I>provided</I>, <I>however</I>,
that the failure of the Sales Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or
affect the Sales Agent&rsquo;s right to rely on the representations and warranties made by the Company in this Agreement, and <I>provided</I>,
<I>further</I>, that the only remedy the Sales Agent shall have with respect to the failure by the Company to obtain such consent shall
be to cease making sales under this Agreement); (iv) the Company will furnish to the Sales Agent at the time of filing thereof a copy
of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those
documents available via EDGAR; and (v) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated
by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act (without
reliance on Rule 424(b)(8) of the Securities Act) or, in the case of any documents incorporated by reference, to be filed with the Commission
as required pursuant to the Exchange Act, within the time period prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) <U>Notice of Commission Stop
Orders</U>. The Company will advise the Sales Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance by
the Commission of any stop order suspending the effectiveness of the Registration Statement or any notice objecting to, or other order
preventing or suspending the use of, the Prospectus, of the suspension of the qualification of the Placement Shares for offering or sale
in any jurisdiction, or of the initiation of any proceeding for any such purpose or any examination pursuant to Section 8(e) of the Securities
Act, or if the Company becomes the subject of a proceeding under Section 8A of the Securities Act in connection with the offering of the
Placement Shares; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain
its withdrawal if such a stop order should be issued. Until such time as any stop order is lifted, the Sales Agent shall cease making
offers and sales under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) <U>Delivery of Prospectus;
Subsequent Changes</U>. During any period in which a Prospectus relating to the Placement Shares is required to be delivered by the Sales
Agent under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement
may be satisfied pursuant to Rule 153 or Rule 172 under the Securities Act), the Company will comply with all requirements imposed upon
it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive
proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or
any other provision of or under the Exchange Act. If during such period any event occurs as a result of which the Prospectus as then amended
or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement
the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Sales Agent to suspend
the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus
(at the expense of the Company) so as to correct such statement or omission or effect such compliance; <I>provided</I>, <I>however</I>,
that the Company may delay any such amendment or supplement if, in the reasonable judgment of the Company, it is in the best interests
of the Company to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) <U>Listing of Placement Shares</U>.
During any period in which the Prospectus relating to the Placement Shares is required to be delivered by the Sales Agent under the Securities
Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant
to Rule&nbsp;153 or Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to cause the Placement
Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions as the
Sales Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement
Shares; <I>provided</I>, <I>however</I>, that the Company shall not be required in connection therewith to qualify as a foreign corporation
or dealer in securities or file a general consent to service of process in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(e) <U>Delivery of Registration
Statement and Prospectus</U>. The Company will furnish to the Sales Agent and its counsel (at the expense of the Company) copies of the
Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements
to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the
Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period
that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the
Sales Agent may from time to time reasonably request and, at the Sales Agent&rsquo;s request, will also furnish copies of the Prospectus
to each exchange or market on which sales of the Placement Shares may be made; <I>provided</I>, <I>however</I>, that the Company shall
not be required to furnish any document (other than the Prospectus) to the Sales Agent to the extent such document is available on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(f) <U>Earnings Statement</U>.
The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after
the end of the Company&rsquo;s current fiscal quarter, an earnings statement of the Company and its subsidiaries (which need not be audited)
covering a 12-month period that complies with Section 11(a) and Rule 158 of the Securities Act. The terms &ldquo;earnings statement&rdquo;
and &ldquo;make generally available to its security holders&rdquo; shall have the meanings set forth in Rule 158 under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(g) <U>Expenses</U>. The Company,
whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated in accordance with the provisions
of <U>Section 11</U> hereunder, will pay the following expenses all incident to the performance of its obligations hereunder, including,
but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and
supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the
Placement Shares, including any stock or other transfer taxes and any stamp or other duties payable upon the sale, issuance or delivery
of the Placement Shares to the Sales Agent, (iii) the fees and disbursements of the counsel, accountants and other advisors to the Company
in connection with the transactions contemplated by this Agreement; (iv) the qualification of the Placement Shares under securities laws
in accordance with the provisions of <U>Section 7(d)</U> of this Agreement, including filing fees (<I>provided</I>, <I>however</I>, that
any fees or disbursements of counsel for the Sales Agent in connection therewith shall be paid by the Sales Agent except as set forth
in (ix) below), (v) the printing and delivery to the Sales Agent of copies of the Prospectus and any amendments or supplements thereto,
and of this Agreement, (vi) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for
trading on the Exchange, (vii) the fees and expenses of the transfer agent or registrar for the Common Stock; (viii) filing fees and expenses,
if any, of the Commission and the FINRA Corporate Financing Department (<I>provided</I>, <I>however</I>, that any fees or disbursements
of counsel for the Sales Agent in connection therewith shall be paid by the Sales Agent except as set forth in (ix) below) and (ix) the
Company shall reimburse the Sales Agent for its out-of-pocket expenses (including but not limited to the reasonable and documented fees
and expenses of counsel to the Sales Agent) (A) in an amount not to exceed $50,000 prior to the execution of this Agreement and (B)(1)
in reasonable amounts to be mutually agreed upon by the Company and the Sales Agent from time to time after the date of this Agreement
for each Representation Date with respect to which the Company is obligated to deliver a certificate for which no waiver is applicable,
provided with respect to this clause (B) the Sales Agent has reasonably incurred such fees and expenses of its counsel in connection with
any &ldquo;bring-down&rdquo; due diligence investigation of the Company in connection with such Representation Date and (2) the Company&rsquo;s
reimbursement obligation shall not exceed $10,000 per fiscal year and the total reimbursement obligation under this clause (ix) shall
in no event exceed $50,000 in the aggregate, unless otherwise mutually agreed in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(h) <U>Use of Proceeds</U>. The
Company will use the Net Proceeds as described in the Prospectus in the section entitled &ldquo;Use of Proceeds.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(i) <U>Notice of Other Sales</U>.
The Company (I) shall provide the Sales Agent notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells,
grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions
of this Agreement) or securities convertible into or exchangeable for Common Stock, or warrants or any rights to purchase or acquire Common
Stock, during the period beginning on the fifth (5th) Trading Day immediately prior to the date on which any Placement Notice is delivered
to the Sales Agent hereunder and ending on the fifth (5th) Trading Day immediately following the final Settlement Date with respect to
Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale
of all Placement Shares covered by a Placement Notice, the fifth (5th) Trading Day immediately following the date of such suspension or
termination), and (II) will not directly or indirectly in any other &ldquo;at-the-market&rdquo; or continuous equity transaction offer
to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered
pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire,
Common Stock prior to the termination of this Agreement; <I>provided</I>, <I>however</I>, that such notice requirements or restrictions,
as the case may be, will not be required in connection with the Company&rsquo;s issuance or sale of (i) Common Stock, options to purchase
Common Stock, other equity awards or Common Stock issuable upon the exercise of options or other equity awards, pursuant to any employee
or director stock option or benefits plan, stock ownership plan or dividend reinvestment plan of the Company whether now in effect or
hereafter implemented, (ii) Common Stock issuable upon exchange, conversion or redemption of securities or the exercise of warrants, options
or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR and (iii) Common Stock or securities
convertible into or exchangeable for Common Stock as consideration for mergers, acquisitions, sale or purchase of assets or other business
combinations or strategic alliances occurring after the date of this Agreement which are not issued for capital raising purposes. Notwithstanding
the foregoing, the Company shall provide the Sales Agent notice at least two (2) days prior to pursuing any private or public offerings
of equity and/or other securities (including debt securities) in one or more transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(j) <U>Change of Circumstances</U>.
The Company will, at any time during a fiscal quarter in which the Company intends to tender a Placement Notice or sell Placement Shares,
advise the Sales Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would
alter or affect in any material respect any opinion, certificate, letter or other document provided to the Sales Agent pursuant to this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(k) <U>Due Diligence Cooperation</U>.
The Company will cooperate with any reasonable due diligence review conducted by the Sales Agent or its agents in connection with the
transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate
officers, during regular business hours and at the Company&rsquo;s principal offices, as the Sales Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(l) <U>Required Filings Relating
to Placement of Placement Shares</U>. The Company shall set forth in each Annual Report on Form 10-K and Quarterly Report on Form 10-Q
filed by the Company with the Commission in respect of any quarter in which sales of Placement Shares were made by or through the Sales
Agent under this Agreement, with regard to the relevant period, the amount of Placement Shares sold to or through the Sales Agent, the
Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent with respect to such sales of Placement Shares.
To the extent that the filing of a prospectus supplement with the Commission with respect to any sales of Placement Shares becomes required
under Rule 424(b) under the Securities Act, the Company agrees that, on or before such dates as the Securities Act shall require, the
Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act,
which prospectus supplement will set forth, with regard to the relevant period, the amount of Placement Shares sold to or through the
Sales Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent with respect to such Placement
Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were
effected as may be required by the rules or regulations of such exchange or market. The Company shall afford the Sales Agent and its counsel
with a reasonable opportunity to review and comment upon, shall consult with the Sales Agent and its counsel on the form and substance
of, and shall give due consideration to all such comments from the Sales Agent or its counsel on, any such filing prior to the issuance,
filing or public disclosure thereof; provided, however, that the Company shall not be required to submit for review (A) any portion of
any periodic reports filed with the Commission under the Exchange Act other than the specific disclosure relating to any sales of Placement
Shares and (B) any disclosure contained in periodic reports filed with the Commission under the Exchange Act if it shall have previously
provided the same disclosure for review in connection with a previous filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(m) <U>Representation Dates; Certificate</U>.
On or prior to the date the first Placement Notice is given hereunder and each time the Company (i) files the Prospectus relating to the
Placement Shares or amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares (other than (A)&nbsp;a
prospectus supplement filed in accordance with <U>Section 7(l)</U> of this Agreement or (B) a supplement or amendment that relates to
an offering of securities other than the Placement Shares) by means of a post-effective amendment, sticker, or supplement but not by means
of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement Shares; (ii) files
an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended financial information or a material
amendment to the previously filed Form 10-K); (iii) files a quarterly report on Form 10-Q under the Exchange Act; or (iv) files a current
report on Form 8-K containing amended financial information (other than an earnings release, to &ldquo;furnish&rdquo; information pursuant
to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain
properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act (each
date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &ldquo;<B><U>Representation Date</U></B>&rdquo;),
the Company shall furnish the Sales Agent within three (3) Trading Days after each Representation Date with a certificate, in the form
attached hereto as <U>Exhibit 7(m)</U>. The requirement to provide a certificate under this <U>Section 7(m)</U> shall be waived for any
Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur
of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date)
and the next occurring Representation Date; <I>provided</I>, <I>however</I>, that such waiver shall not apply for any Representation Date
on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, if the Company subsequently decides to sell
Placement Shares following a Representation Date when the Company relied on such waiver and did not provide the Sales Agent with a certificate
under this <U>Section 7(m)</U>, then before the Company delivers the Placement Notice or the Sales Agent sells any Placement Shares, the
Company shall provide the Sales Agent with a certificate, in the form attached hereto as <U>Exhibit 7(m)</U>, dated the date of the Placement
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(n) <U>Legal Opinions</U>. On or
prior to the date the first Placement Notice is given hereunder, the Company shall cause to be furnished to the Sales Agent the written
opinion and negative assurance of Dickinson Wright, as counsel to the Company, or other counsel reasonably satisfactory to the Sales Agent
(&ldquo;<B><U>SEC Counsel</U></B>&rdquo;), in each case substantially in the forms previously agreed between the Company and the Sales
Agent. Thereafter, within three (3) Trading Days after each Representation Date with respect to which the Company is obligated to deliver
a certificate pursuant to <U>Section 7(m)</U> for which no waiver is applicable pursuant to <U>Section&nbsp;7(m)</U>, and not more than
once per calendar quarter, the Company shall cause to be furnished to the Sales Agent the written opinions and negative assurance of SEC
Counsel substantially in the forms previously agreed between the Company and the Sales Agent, modified, as necessary, to relate to the
Registration Statement and the Prospectus as then amended or supplemented; <I>provided</I>, <I>however</I>, that if SEC Counsel has previously
furnished to the Sales Agent such written opinions and negative assurance of such counsel, in each case substantially in the forms previously
agreed between the Company and the Sales Agent, then SEC Counsel may, in respect of any future Representation Date, furnish the Sales
Agent with a letter signed by such counsel (each, a &ldquo;<B><U>Reliance Letter</U></B>&rdquo;) in lieu of such opinions and negative
assurance of such counsel (as applicable) to the effect that the Sales Agent may rely on the prior opinions and negative assurance of
such counsel (as applicable) delivered pursuant to this <U>Section 7(n)</U> to the same extent as if it were dated the date of such Reliance
Letter (except that statements in such prior opinions and negative assurance (as applicable) shall be deemed to relate to the Registration
Statement and the Prospectus as amended or supplemented to the date of such Reliance Letter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(o) <U>Comfort Letter</U>. On or
prior to the date the first Placement Notice is given hereunder and within three (3) Trading Days after each subsequent Representation
Date with respect to which the Company is obligated to deliver a certificate pursuant to <U>Section 7(m)</U> for which no waiver is applicable
pursuant to <U>Section&nbsp;7(m)</U>, other than a Representation Date under <U>Section 7(m)(iii) </U>or <U>Section 7(m)(iv)</U> unless
with respect to a Representation Date under <U>Section 7(m)(iv)</U> the Sales Agent reasonably requests delivery thereof, the Company
shall cause its independent accountants (or its prior independent accountants to the extent such independent accountants have audited
any of the financial statements in the Prospectus) to furnish the Sales Agent letters (the &ldquo;<B><U>Comfort Letters</U></B>&rdquo;),
dated the date that the Comfort Letter is delivered, in form and substance satisfactory to the Sales Agent, (i) confirming that they are
an independent registered public accounting firm within the meaning of the Securities Act, the Exchange Act and the rules and regulations
of the PCAOB and are in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation
S-X of the Commission, (ii)&nbsp;stating, as of such date, the conclusions and findings of such firm with respect to the financial information
and other matters ordinarily covered by accountants&rsquo; &ldquo;comfort letters&rdquo; to the Sales Agent in connection with registered
public offerings (the first such letter, the &ldquo;<B><U>Initial Comfort Letter</U></B>&rdquo;) and (iii)&nbsp;updating the Initial Comfort
Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as
necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(p) <U>CFO Certification</U>. On
or prior to the date the first Placement Notice is given hereunder and within three (3) Trading Days after each subsequent Representation
Date with respect to which the Company is obligated to deliver a certificate pursuant to <U>Section 7(m)</U> for which no waiver is applicable
pursuant to <U>Section&nbsp;7(m)</U>, the Company shall furnish the Sales Agent with certificates, signed on behalf of the Company by
its Chief Financial Officer (each, a &ldquo;<B><U>CFO Certificate</U></B>&rdquo;), dated the date that the CFO Certificate is delivered,
in form and substance satisfactory to the Sales Agent and its counsel, certifying as to such financial and statistical information, forward-looking
statements and other matters as the Sales Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(q) <U>Market Activities</U>. The
Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably
be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of the Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting
purchases of the Placement Shares other than the Sales Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(r) <U>Insurance</U>. The Company
and its subsidiaries shall maintain, or cause to be maintained, insurance in such amounts and covering such risks as is reasonable and
customary for the business in which it is engaged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(s) <U>Investment Company Act</U>.
The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its subsidiaries or, after giving
effect to the offering and sale of the Placement Shares and the application of proceeds therefrom as described in the Prospectus, will
be, an &ldquo;investment company&rdquo; within the meaning of such term under the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(t) <U>Securities Act and Exchange
Act</U>. The Company will use its best efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange
Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Shares as
contemplated by the provisions hereof and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(u) <U>No Offer to Sell</U>. Other
than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Sales Agent in its capacity as principal
or agent hereunder, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales Agent in its
capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the
Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement
Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(v) <U>Sarbanes-Oxley Act</U>.
The Company and its subsidiaries will use their reasonable best efforts to comply with all effective applicable provisions of the Sarbanes-Oxley
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(w) <U>Transfer Agent</U>. The
Company shall maintain, at its sole expense, a registrar and transfer agent for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
to the Sales Agent&rsquo;s Obligations</U>. The obligations of the Sales Agent hereunder with respect to a Placement will be subject to
the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the
Company of its obligations hereunder, to the completion by the Sales Agent of a due diligence review satisfactory to the Sales Agent in
its reasonable judgment, and to the continuing satisfaction (or waiver by the Sales Agent in its sole discretion) of the following additional
conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) <U>Registration Statement Effective</U>.
The Registration Statement shall be effective and shall be available for the sale of all Placement Shares contemplated to be issued by
any Placement Notice which have not yet been issued and sold pursuant to such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) <U>Securities Act Filings Made</U>.
The Company shall have filed with the Commission the ATM Prospectus pursuant to Rule 424(b) under the Securities Act not later than the
Commission&rsquo;s close of business on the second Business Day following the date of this Agreement. All other filings with the Commission
required by Rule 424(b) or Rule 433 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder
shall have been made within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on Rule 424(b)(8) of
the Securities Act) or Rule 433, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) <U>No Material Notices</U>.
None of the following events shall have occurred and be continuing: (i)&nbsp;receipt by the Company or any of its subsidiaries of any
request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness
of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement
or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of
any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for
sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the occurrence of any event that makes
any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related
Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading
and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) <U>No Misstatement or Material
Omission</U>. The Sales Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement
thereto, contains an untrue statement of fact that in the Sales Agent&rsquo;s reasonable opinion is material, or omits to state a fact
that in the Sales Agent&rsquo;s reasonable opinion is material and is required to be stated therein or is necessary to make the statements
therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(e) <U>Material Changes</U>. Except
as contemplated in the Prospectus, or disclosed in the Company&rsquo;s reports filed with the Commission, there shall not have been any
material adverse change in the authorized capital stock of the Company or any Material Adverse Change or any development that could reasonably
be expected to result in a Material Adverse Change, or any downgrading in or withdrawal of the rating assigned to any of the Company&rsquo;s
securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it
has under surveillance or review its rating of any of the Company&rsquo;s securities (other than asset backed securities), the effect
of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Sales Agent (without
relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable
to proceed with the offering of the Placement Shares on the terms and in the manner contemplated by this Agreement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(f) <U>Representation Certificate</U>.
The Sales Agent shall have received the certificate required to be delivered pursuant to <U>Section 7(m)</U> on or before the date on
which delivery of such certificate is required pursuant to <U>Section 7(m)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(g) <U>Legal Opinion</U>. The Sales
Agent shall have received the opinion and negative assurances of SEC Counsel required to be delivered pursuant <U>Section 7(n)</U> on
or before the date on which such delivery of such opinions and negative assurances is required pursuant to <U>Section 7(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(h) <U>Comfort Letter</U>. The
Sales Agent shall have received the Comfort Letter required to be delivered pursuant <U>Section 7(o)</U> on or before the date on which
such delivery of such Comfort Letter is required pursuant to <U>Section 7(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(i) <U>CFO Certificate</U>. The
Sales Agent shall have received the CFO Certificate required to be delivered pursuant to <U>Section 7(p) </U>on or before the date on
which delivery of such CFO Certificate is required pursuant to <U>Section 7(p)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(j) <U>Secretary&rsquo;s Certificate</U>.
On or prior to the date the first Placement Notice is given hereunder, the Sales Agent shall have received a certificate, signed on behalf
of the Company by its corporate Secretary, certifying as to (i) the certificate of incorporation of the Company (as the same may be amended
or restated from time to time), (ii) the bylaws of the Company (as the same may be amended or restated from time to time), and (iii) the
resolutions of the Board of Directors of the Company (or a committee thereof) authorizing the execution, delivery and performance of this
Agreement and the issuance of the Placement Shares and (iii) the incumbency of the officers duly authorized to execute this Agreement
and the other documents contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(k) <U>No Suspension</U>. Trading
in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(l) <U>Other Materials</U>. On
each date on which the Company is required to deliver a certificate pursuant to <U>Section 7(m)</U>, the Company shall have furnished
to the Sales Agent such appropriate further opinions, certificates, letters and documents as the Sales Agent may have reasonably requested.
All such opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof. The Company will
furnish the Sales Agent with such conformed copies of such opinions, certificates, letters and other documents as the Sales Agent shall
have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(m) <U>Approval for Listing</U>.
The Placement Shares shall either have been (i) approved for listing on the Exchange, subject only to notice of issuance, or (ii) the
Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(n) <U>No Termination Event</U>.
There shall not have occurred any event that would permit the Sales Agent to terminate this Agreement pursuant to <U>Section 11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(o) <U>FINRA</U>. The Sales Agent
shall have received a letter from the Corporate Financing Department of FINRA confirming that such department has determined to raise
no objection with respect to the fairness or reasonableness of the terms and arrangements related to the sale of the Placement Shares
pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) <U>Company Indemnification</U>.
The Company agrees to indemnify and hold harmless the Sales Agent, the directors, officers, members, partners, employees and agents of
the Sales Agent, each Sales Agent Affiliate, and the directors, officers, members, shareholders, partners, employees and agents of each
Sales Agent Affiliate, if any, from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited
to, any and all reasonable investigative, legal and other expenses incurred in connection with, and any and all amounts paid in settlement
(in accordance with <U>Section 9(c)</U>) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying
parties or between any indemnified party and any third party, or otherwise, or any claim asserted), as and when incurred, to which the
Sales Agent, or any such person, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law
or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based,
directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement
or the Prospectus or any amendment or supplement thereto or in any Issuer Free Writing Prospectus or in any application or other document
executed by or on behalf of the Company or based on written information furnished by or on behalf of the Company filed in any jurisdiction
in order to qualify the Common Stock under the securities laws thereof or filed with the Commission, (y) the omission or alleged omission
to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading or
(z)&nbsp;any breach or alleged breach by any of the indemnifying parties of any of their respective representations, warranties and agreements
contained in this Agreement; <I>provided, however</I>, that this indemnity agreement shall not apply to the extent that a court of competent
jurisdiction has made a finding, not subject to appeal or modification, that such loss, claim, liability, expense or damage arises from
the sale of the Placement Shares pursuant to this Agreement and is caused directly by an untrue statement or omission made in reliance
upon and in strict conformity with written information relating to the Sales Agent and furnished to the Company by the Sales Agent expressly
for inclusion in any document as described in clause (x) of this <U>Section 9(a)</U>. This indemnity agreement will be in addition to
any liability that the Company might otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) <U>The Sales Agent Indemnification</U>.
The Sales Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration
Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act or (ii) is controlled by or is under common control with the Company (each, a &ldquo;<B><U>Company Affiliate</U></B>&rdquo;)
from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable
investigative, legal and other expenses incurred in connection with, and any and all amounts paid in settlement (in accordance with <U>Section
9(c)</U>) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified
party and any third party, or otherwise, or any claim asserted), as and when incurred, to which any such Company Affiliate, may become
subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise,
insofar as a court of competent jurisdiction has made a finding, not subject to appeal or modification, that such losses, claims, liabilities,
expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement or the Prospectus or any amendment or supplement thereto, or (y) the omission or alleged
omission to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading;
<I>provided</I>, <I>however</I>, that this indemnity agreement shall apply only to the extent that such loss, claim, liability, expense
or damage is caused directly by an untrue statement or omission made in reliance upon and in strict conformity with written information
relating to the Sales Agent and furnished to the Company by the Sales Agent expressly for inclusion in any document as described in clause
(x) of this <U>Section 9(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) <U>Procedure</U>. Any party
that proposes to assert the right to be indemnified under this <U>Section 9</U> will, promptly after receipt of notice of commencement
of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this <U>Section
9</U>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission
so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified
party otherwise than under this <U>Section 9</U> and (ii) any liability that it may have to any indemnified party under the foregoing
provision of this <U>Section 9</U> unless, and only to the extent that, such omission results in the forfeiture of substantive rights
or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party
of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written
notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly
with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the
indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying
party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable
costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have
the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense
of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying
party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it
or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential
conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which
case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the
indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice
of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the
expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any
proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more
than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees,
disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will
not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall,
without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending
or threatened claim, action or proceeding relating to the matters contemplated by this <U>Section 9</U> (whether or not any indemnified
party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from
all liability arising or that may arise out of such claim, action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) <U>Contribution</U>. In order
to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs
of this <U>Section 9</U> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the
Sales Agent, the Company and the Sales Agent will contribute to the total losses, claims, liabilities, expenses and damages (including
any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action,
suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Sales
Agent, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration
Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Sales Agent may be subject
in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Sales Agent
on the other. The relative benefits received by the Company on the one hand and the Sales Agent on the other hand shall be deemed to be
in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company
bear to the total compensation received by the Sales Agent from the sale of Placement Shares on behalf of the Company. If, but only if,
the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in
such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative
fault of the Company, on the one hand, and the Sales Agent, on the other, with respect to the statements or omission that resulted in
such loss, claim, liability, expense or damage, or action in respect thereof,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">as well as any other relevant equitable considerations with
respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or
the Sales Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such
statement or omission. The Company and the Sales Agent agree that it would not be just and equitable if contributions pursuant to this
<U>Section&nbsp;9(d)</U> were to be determined by pro rata allocation or by any other method of allocation that does not take into account
the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability,
expense, or damage, or action in respect thereof, referred to above in this <U>Section&nbsp;9(d)</U> shall be deemed to include, for the
purpose of this <U>Section 9(d)</U>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim to the extent consistent with <U>Section 9(c)</U> hereof. Notwithstanding the foregoing provisions
of this <U>Section 9(d)</U>, the Sales Agent shall not be required to contribute any amount in excess of the commissions received by it
under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <U>Section
9(d)</U>, any person who controls a party to this Agreement within the meaning of the Securities Act will have the same rights to contribution
as that party (and any officers, directors, members, partners, employees or agents of the Sales Agent and each broker dealer affiliate
of the Sales Agent will have the same rights to contribution as the Sales Agent), and each officer of the Company who signed the Registration
Statement and each director of the Company will have the same rights to contribution as the Company, subject in each case to the provisions
hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect
of which a claim for contribution may be made under this <U>Section 9(d)</U>, will notify any such party or parties from whom contribution
may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other
obligation it or they may have under this <U>Section 9(d)</U> except to the extent that the failure to so notify such other party materially
prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant
to the last sentence of <U>Section 9(c)</U> hereof, no party will be liable for contribution with respect to any action or claim settled
without its written consent if such consent is required pursuant to <U>Section 9(c)</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Agreements to Survive Delivery</U>. The indemnity and contribution agreements contained in <U>Section 9</U> of this Agreement and
all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective
dates, regardless of (i) any investigation made by or on behalf of the Sales Agent, any controlling person of the Sales Agent, or the
Company (or any of their respective officers, directors, members or controlling persons), (ii) delivery and acceptance of the Placement
Shares and payment therefor or (iii) any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">11. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) The Sales Agent shall have
the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i) any Material Adverse Change, or any
development that could reasonably be expected to result in a Material Adverse Change has occurred that, in the reasonable judgment of
the Sales Agent, may materially impair the ability of the Sales Agent to sell the Placement Shares hereunder, (ii) the Company shall have
failed, refused or been unable to perform any agreement on its part to be performed hereunder; <I>provided</I>, <I>however</I>, in the
case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion, or letter required under
<U>Sections 7(m)</U>, <U>7(n)</U>, <U>7(o)</U>, <U>7(p)</U> or <U>7(q)</U>, the Sales Agent&rsquo;s right to terminate shall not arise
unless such failure to deliver (or cause to be delivered) continues for more than thirty (30) days from the date such delivery was required,
(iii) any other condition of the Sales Agent&rsquo;s obligations hereunder is not fulfilled, or (iv) any suspension or limitation of trading
in the Placement Shares or in securities generally on the Exchange shall have occurred (including automatic halt in trading pursuant to
market-decline triggers, other than those in which solely program trading is temporarily halted), or a major disruption of securities
settlements or clearing services in the United States shall have occurred, or minimum prices for trading have been fixed on the Exchange.
Any such termination shall be without liability of any party to any other party except that the provisions of <U>Section 7(g)</U> (Expenses),
<U>Section 9</U> (Indemnification and Contribution), <U>Section 10</U> (Representations and Agreements to Survive Delivery), <U>Section
11(f)</U>, <U>Section 16</U> (Applicable Law; Consent to Jurisdiction) and <U>Section 17</U> (Waiver of Jury Trial) hereof shall remain
in full force and effect notwithstanding such termination. If the Sales Agent elects to terminate this Agreement as provided in this <U>Section
11(a)</U>, the Sales Agent shall provide the required notice as specified in <U>Section 12</U> (Notices).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) The Company shall have the
right, by giving ten (10) days&rsquo; notice as hereinafter specified in <U>Section 12</U>, to terminate this Agreement in its sole discretion
at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that
the provisions of <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section 17</U>
hereof shall remain in full force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) The Sales Agent shall have
the right, by giving ten (10) days&rsquo; notice as hereinafter specified in <U>Section 12</U>, to terminate this Agreement in its sole
discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party
except that the provisions of <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section
17</U> hereof shall remain in full force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) Unless earlier terminated pursuant
to this <U>Section 11</U>, this Agreement shall automatically terminate upon the earlier to occur of (i) issuance and sale of all of the
Placement Shares to or through the Sales Agent on the terms and subject to the conditions set forth herein and (ii) the expiration of
the Registration Statement on the third (3<SUP>rd</SUP>) anniversary of the initial effective date of the Registration Statement pursuant
to Rule 415(a)(5) under the Securities Act; <I>provided</I> that the provisions of <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>,
<U>Section 11(f)</U>, <U>Section&nbsp;16</U> and <U>Section 17</U> hereof shall remain in full force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(e) This Agreement shall remain
in full force and effect unless terminated pursuant to <U>Sections&nbsp;11(a)</U>, <U>(b)</U>, <U>(c)</U> or <U>(d)</U> above or otherwise
by mutual agreement of the parties; <I>provided</I>, <I>however</I>, that any such termination by mutual agreement shall in all cases
be deemed to provide that <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section
17</U> shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(f) Any termination of this Agreement
shall be effective on the date specified in such notice of termination; <I>provided</I>, <I>however</I>, that such termination shall not
be effective until the close of business on the date of receipt of such notice by the Sales Agent or the Company, as the case may be.
If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such termination shall not become effective
until the close of business on such Settlement Date and such Placement Shares shall settle in accordance with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">12. <U>Notices</U>. All notices
or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall
be in writing, unless otherwise specified, and if sent to the Sales Agent, shall be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Dawson James Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">101 North Federal Highway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Suite 600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Boca Raton, Fl 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Attention: Richard Aulicino</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Email: raulicino@dawsonjames.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Nelson Mullins Riley &amp; Scarborough LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">301 Hillsborough Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Raleigh, NC 27603</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Attention: W. David Mannheim, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Email: david.mannheim@nelsonmullins.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">and if to the Company, shall be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Lunai Bioworks Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">3400 Cottage Way<BR>
Suite G2 #32562</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Sacramento, CA 95825</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Attention: David H. Weinstein<BR>
Email: dweinstein@renovarogroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Dickinson Wright</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">350 East Las Olas Blvd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Suite 1750&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">Ft. Lauderdale, FL 33301<BR>
Attention: Joel D. Mayersohn, Esq.<BR>
Email: jmayersohn@dickinson-wright.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Each party may change such address
for notices by sending to the other party to this Agreement written notice of a new address for such purpose. Each such notice or other
communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow)
on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day,
(ii)&nbsp;on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually
received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this
Agreement, &ldquo;<B><U>Business Day</U></B>&rdquo; shall mean any day on which the Exchange and commercial banks in the City of New York
are open for business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">An electronic communication (&ldquo;<B><U>Electronic
Notice</U></B>&rdquo;) shall be deemed written notice for purposes of this <U>Section 12</U> if sent to the electronic mail address specified
by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending Electronic Notice
receives confirmation of receipt by the receiving party (other than pursuant to auto-reply). Any party receiving Electronic Notice may
request and shall be entitled to receive the notice on paper, in a nonelectronic form (&ldquo;<B><U>Nonelectronic Notice</U></B>&rdquo;)
which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">13. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the Company and the Sales Agent and their respective
successors and permitted assigns and, as to <U>Sections 5(b)</U> and <U>9</U>, the other indemnified parties specified therein. References
to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing
in this Agreement, express or implied, is intended to confer upon any other person any rights, remedies, obligations or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under
this Agreement without the prior written consent of the other party; <I>provided</I>, <I>however</I>, that the Sales Agent may assign
its rights and obligations hereunder to an affiliate of the Sales Agent without obtaining the Company&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">14. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments
for Share Splits</U>. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to
take into account any share split, share dividend or similar event effected with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">15. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement; Amendment; Severability</U>. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued
pursuant hereto) and any other writing entered into by the parties relating to this Agreement constitutes the entire agreement and supersedes
all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto. Neither this Agreement
nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Sales Agent. In the event that
any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable
as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent
that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal
or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder
of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable
Law; Consent to Jurisdiction</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#9;(a)&#9;This Agreement shall
be governed by, and construed in accordance with, the internal laws of the State of New York, without regard to the principles of conflicts
of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of
New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such
suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#9;(b)&#9;The Sales Agent and
the Company agree that any suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby
may be instituted in any federal or New York State court located in the City and County of New York (a &ldquo;<U>New York Court</U>&rdquo;),
and waive any objection which they may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submit to
the non-exclusive jurisdiction of such courts in any suit, action or proceeding. The Company hereby irrevocably designates and appoints
Dickinson-Wright (the &ldquo;<U>Process Agent</U>&rdquo;) as its authorized agent upon whom process may be served in any claim brought
against the Company, it being understood that the designation and appointment of the Process Agent as such authorized agent shall become
effective immediately without any further action on the part of the Company. The Company represents to the Sales Agent that it has notified
the Process Agent of such designation and appointment and that the Process Agent has accepted the same. The Company hereby irrevocably
authorizes and directs the Process Agent to accept such service. The Company further agrees that service of process upon the Process Agent
and written notice of said service to the Company, mailed by first-class mail and delivered to the Process Agent, shall be deemed in every
respect effective service of process upon the Company in any such claim. Nothing herein shall affect the right of the Sales Agent, its
partners, directors, officers and members, any person who controls the Sales Agent within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act, or any &ldquo;affiliate&rdquo; (within the meaning of Rule 405 under the Securities Act) of the
Sales Agent, or the successors and assigns of all of the foregoing persons, to serve process in any other manner permitted by law. The
provisions of this Section 16 shall survive any termination of this Agreement, in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">17. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver
of Jury Trial</U>. The Company and the Sales Agent each hereby irrevocably waives any right it may have to a trial by jury in respect
of any claim based upon or arising out of this Agreement or any transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">18. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Fiduciary Relationship</U>. The Company acknowledges and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) the Sales Agent is acting solely
as agent in connection with the sale of the Placement Shares contemplated by this Agreement and the process leading to such transactions,
and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders),
creditors or employees or any other party, on the one hand, and the Sales Agent, on the other hand, has been or will be created in respect
of any of the transactions contemplated by this Agreement, irrespective of whether the Sales Agent has advised or is advising the Company
on other matters, and the Sales Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement,
except the obligations expressly set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(b) the Company is capable of evaluating
and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(c) the Sales Agent has not provided
any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement, and the Company has consulted
its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(d) the Company has been advised
and is aware that the Sales Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ
from those of the Company and that the Sales Agent has no obligation to disclose such interests and transactions to the Company by virtue
of any fiduciary, advisory or agency relationship; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(e) the Company waives, to the
fullest extent permitted by law, any claims it may have against the Sales Agent, for breach of fiduciary duty or alleged breach of fiduciary
duty and agrees that the Sales Agent shall have no liability (whether direct or indirect, in contract, tort or otherwise) to the Company
in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including
stockholders, partners, employees or creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">19. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Use
of Information</U>. The Sales Agent may not provide any information gained in connection with this Agreement and the transactions contemplated
by this Agreement, including due diligence, to any third party other than its legal counsel advising it on this Agreement unless expressly
approved by the Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">20. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">21. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect
of Headings; Knowledge of the Company</U>. The section and Exhibit headings herein are for convenience only and shall not affect the construction
hereof. All references in this Agreement to the &ldquo;knowledge of the Company&rdquo; or the &ldquo;Company&rsquo;s knowledge&rdquo;
or similar qualifiers shall mean the actual knowledge of the directors and officers of the Company, after due inquiry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">22. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
As used in this Agreement, the following term has the meaning set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">(a) &ldquo;<I>Applicable Time</I>&rdquo;
means the date of this Agreement, each Representation Date, each date on which a Placement Notice is given, each Point of Sale, and each
Settlement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>[Remainder of Page Intentionally Blank]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">If the foregoing correctly sets
forth the understanding between the Company and the Sales Agent, please so indicate in the space provided below for that purpose, whereupon
this letter shall constitute a binding agreement between the Company and the Sales Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>LUNAI BIOWORKS INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David H. Weinstein&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Name: David H. Weinstein</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>ACCEPTED as of the date first-above written:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>DAWSON JAMES SECURITIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Robert D. Keiser, Jr.&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Name: Robert D. Keiser, Jr.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 29; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form of Placement Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From:</FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lunai Bioworks Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dawson James Securities, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">InvestmentBanking@DawsonJames.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Notice</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________, 202__</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Pursuant to the terms and subject
to the conditions contained in the Sales Agreement (the &ldquo;<B><U>Sales Agreement</U></B>&rdquo;) between Lunai Bioworks Inc., a Delaware
corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and Dawson James Securities, Inc. (the &ldquo;<B><U>Sales Agent</U></B>&rdquo;),
dated December 2, 2025, the Company hereby requests that the Sales Agent sell up to _______ shares of the Company&rsquo;s common stock
(the &ldquo;<B><U>Placement Shares</U></B>&rdquo;), at a minimum market price of $________ per share, during the time period beginning
[month, day, time] and ending [month, day, time] [and with no more than ___________ Placement Shares sold in any one Trading Day].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">[The Company may include such other
sale parameters as it deems appropriate.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Capitalized terms used and not
defined herein shall have the respective meanings assigned to them in the Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Notice Parties</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Lunai Bioworks Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">3400 Cottage Way<BR>
Suite G2 #32562</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Sacramento, CA 95825</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attention: David H. Weinstein, Chief Executive Officer<BR>
Email: dweinstein@renovarogroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attn: Nathan Fuentes, Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email: nfuentes@renovarogroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dickinson Wright</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">350 East Las Olas Blvd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 1750</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ft. Lauderdale, FL 33301<BR>
Attention: Joel D. Mayersohn, Esq.<BR>
Email: jmayersohn@dickinson-wright.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>The Sales Agent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">InvestmentBanking@DawsonJames.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">With copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">cwachowiz@dawsonjames.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nelson Mullins Riley&nbsp;&amp; Scarborough LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">301 Hillsborough Street, Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Raleigh, NC 27603</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">E-Mail: david.mannheim@nelsonmullins.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B><U>SCHEDULE 3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company shall pay to the Sales Agent in cash,
upon each sale of Placement Shares through the Sales Agent pursuant to this Agreement, an amount equal to 3.0% of the aggregate gross
proceeds from each sale of Placement Shares.<SUP>*</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><SUP>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SUP>The
foregoing rate of compensation shall not apply when the Sales Agent purchases Placement Shares on a principal basis, in which case the
Company may sell the Placement Shares to the Sales Agent as principal at a price to be mutually agreed upon by the Company and the Sales
Agent at the relevant Point of Sale pursuant to the applicable Placement Notice (it being hereby acknowledged and agreed that the Sales
Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to the Sales Agreement, except as otherwise
agreed by the Sales Agent and the Company in writing and expressly set forth in a Placement Notice).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Exhibit 7(m)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>OFFICER CERTIFICATE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">The undersigned, the duly qualified
and appointed Chief Financial Officer of Lunai Bioworks Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), does hereby
certify in such capacity and on behalf of the Company, pursuant to <U>Section 7(m)</U> of the Sales Agreement, dated December 2, 2025
(the &ldquo;<B><U>Sales Agreement</U></B>&rdquo;), between the Company and Dawson James Securities, Inc., that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company in <U>Section 6</U> of the Sales Agreement (A) to the extent such representations and warranties
are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct
on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations
and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations
and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof
as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those
representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement
at or prior to the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
of the date hereof, (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein not misleading, (ii) the Prospectus does not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result
of which it is necessary to amend or supplement the Registration Statement or the Prospectus in order to make the statements therein not
untrue or misleading for clauses (i) and (ii) above, respectively, to be true and correct;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
has been no Material Adverse Change since the date as of which information is given in the Prospectus, as amended or supplemented;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company will not be in possession of any material non-public information at the time of delivery of any Placement Notice and/or as long
as such Placement Notice is effective; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
aggregate offering price of the Placement Shares that may be issued and sold pursuant to the Sales Agreement and the maximum number or
amount of Placement Shares that may be sold pursuant to the Sales Agreement have been duly authorized by the Company&rsquo;s board of
directors or a duly authorized committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Terms used herein and not defined herein have the
meanings ascribed to them in the Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: [______]</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>e7056_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_010.jpg" ALT="" STYLE="height: 108px; width: 650px">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 2, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lunai
Bioworks, Inc.<BR>
3400 Cottage Way, Suite G2 #32562 <BR>
Sacramento, CA 95825</FONT></TD>
<TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
&nbsp; &nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 6%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 6%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
<TD STYLE="padding: 0pt; width: 88%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lunai
Bioworks, Inc. <BR>
Securities Registered under Registration Statement on Form S-3<BR>
(File No. 333-282898); Legality of Securities
&nbsp; &nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have acted as special counsel to Lunai Bioworks, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), in connection with the offer and sale from time to time by the Company of up to $11,702,826 shares (the &ldquo;Shares&rdquo;)
of common stock, par value $0.0001 per share, pursuant to pursuant to that certain At-the-Market Offering Sales Agreement dated as of
December 2, 2025 (the &ldquo;Sales Agreement&rdquo;), by and between the Company and Dawson James Securities, Inc. (the &ldquo;Sales Agent&rdquo;).
The shares will be offered and sold pursuant to the prospectus supplement dated December 2, 2025 (the &ldquo;Prospectus Supplement&rdquo;),
filed by the Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) pursuant to Rule 424(b)(5) under the Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), supplementing the prospectus dated November 6, 2024 (the &ldquo;Base Prospectus&rdquo;),
that forms part of the Company&rsquo;s shelf registration statement on Form S-3 (File No. 333-282898) (the &ldquo;Registration Statement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As counsel for the Company, in rendering this opinion,
we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of the Registration Statement,
the Base Prospectus, the Prospectus Supplement, the Company&rsquo;s Certificate of Incorporation (the &ldquo;Certificate&rdquo;) and Amended
and Restated Bylaws (the &ldquo;Bylaws&rdquo;), resolutions of the Company&rsquo;s Board of Directors authorizing the Sales Agreement
and the issuance and sale of the Shares, and such other corporate records, certificates, and documents as we have deemed necessary or
appropriate for the purpose of this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have assumed the genuineness of all signatures,
the legal capacity of natural persons, the authenticity of all items submitted to us as originals, the conformity with originals of all
items submitted to us as copies, and the authenticity of the originals of such copies. As to any facts material to the opinions expressed
herein, we have relied upon statements and representations of officers and other representatives of the Company and public officials.
Based upon the foregoing and subject to the qualifications, assumptions, and limitations set forth herein, we are of the opinion that
the Shares have been duly authorized and, when (i) issued and sold in the manner described in the Registration Statement, the prospectus
contained therein, or any supplement or amendment thereto (including the prospectus supplement describing at the market offerings or
the issuance or pledge of shares as collateral for loan or credit facilities) and (ii) delivered against payment therefor in accordance
with the Sales Agreement, will be validly issued, fully paid, and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We confirm that our opinion herein applies equally
to any Shares issued by the Company under the Registration Statement and the applicable prospectus supplement that are delivered as collateral
to one or more lenders or counterparties in connection with any loan or credit facility, provided such issuance and pledge is effected
in the manner and for the consideration described in the prospectus supplement and the terms of the applicable loan or credit agreement.
In such case, the Shares so issued and pledged as collateral will be duly authorized, validly issued, fully paid, and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We express no opinion herein as to any laws other
than the General Corporation Law of the State of Delaware and the federal laws of the United States of America that, in our experience,
are normally applicable to transactions of the type contemplated by the Sales Agreement. This opinion is rendered as of the date hereof,
and we assume no obligation to update or supplement this opinion to reflect any facts or circumstances that may hereafter come to our
attention or any changes in law that may occur after the date hereof. We do not find it necessary for the purposes of this opinion letter
to cover, and accordingly we express no opinion as to, the application of the securities or blue sky laws of the various states to the
sales of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We hereby consent to the filing of this opinion as
Exhibit 5.1 to the Prospectus Supplement and to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus
and the Prospectus Supplement. In giving this consent, we do not admit that we are within the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dickinson Wright, PLLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FBG; JDM</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #V!<\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AO+NWL+.:[NI5BMX4+R2
M-T51U-35R_B1M2FU>P@70K[4-*A'VB7[+) /,F!^1&$DJ':I&_OD[?0T 5O
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MY7;N(V]%;&1Z \#;UKO_  Y?Q^*O"VC:S=VBQR31)="(Y(1]IY'J.3C/L>M
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M5S@?,,'CK6]10!EZ#X=TWPU8FRTJ*:*VW%A%)<RS!23D[=[';DDG QR<UID
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MCD9&\0C<I(.+2<C\PF#73:UXJT3P[I,>J:OJ$=I:2X\MW5LN2,@!0-Q..V*
M&:OX2TC79[2?4$O'DM"# 8[^>+RV&<, CCYN2-W7WK6E@2:V>W<R!'0H2DC(
MP!&.&!# ^X.?>L[P_P")M&\4V!O=$U"*\@5MK% 05/7!4@$'ZBKU]?VNF64M
M[>W$<%M$,O)(< =A^). !W)Q0!ST7P[\.P6<EG$FII:R%B\"ZQ>!'W$ELKYN
M#DDY]<UTZ(D4:QQJ%10%50,  =JI:-K6G>(=+BU/2KD7-G*6"2A2H;:Q4\$
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MWVJ^.XB-+:4#"]3N*A<>^>?QKJZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLN6EGM;BZED8\O+YS,&)]<J/RKV*TLK>RTZ"P@C"VT$2PI&>0$48 _(5P \
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML?86=9Y)HY;29W#;V+$$,BXQGWS[4 <EXYFM/#NB?#?2M1OK>*YL=4L&F#R
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M0-+MI/'FL^(],4+87EK#"\B#"W,ZLY:1?[P"E!N'!.?0UV-(<[3M(!QP2,T
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MY&W  J3(B/\ QHIV@$<=1V-=_10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%8VL^([325*9\VX(XC4]/KZ4 :TLL<,9DE=40=2QP
M*YO4/&5M QBLHS<2=-W1?_KU@HNL>*[G)8B 'D]$7_$UUNE>'+'2U#!/-G[R
M./Y#M0!B16WB+71NGF-K;MV^[G\*U;/PEIUN0\P:YD[M(>/RK>HH 9%#%"N(
MHU0?[(Q3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445PGC'Q3XM\+6EUJ<>A:=>:9 W6.[?S0G]YE*
M8'X$T =W17@+?M)2&,!?#"!^Y-[D?EL_K75V7Q US6-'AN);.PMH;R'>C6]P
MSR)SC# J #UZ$T =3XB\4BT+V=BP:?H\G4)]/4UCZ!X<EU:3[9>EQ;9SDGYI
M3_A[_P"0GAKPZ=3E%U= BT0].\A]/I7H2JJ*%50J@8  P * &0016T*PPQJD
M:# 51TJ2N-U7XBZ;I7Q T_PE+'F6ZCW-<>8 L3G.U"/4X_4>M=E0 445E:W-
MKL,*'0[.PN9,GS!=SM'Q[;5.3]<4 :M%>$O^T)?6M[+I]SX41KR.0PE8[S W
M@XQ]PYY]Z]7\/W?B>[82:YIFGV4#Q;D2"Y:256./E8%0.F<D$\B@#?HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *YGQ7X+A\7-:"[UC5+6&UE2>*&S:)5$JD[7):
M-FR,],XX'%=-6#JWBW3]&US3=(N8;QKC4)!'"Z0'R\GU<X'U R1QQ6E.E.K+
ME@KO?[M6)M+<V;:%X+:.*2XEN710&FE"AG/J=H"Y^@ KC;CX7Z1<:1J6D?VC
MJT>FWUP;K[+',@6&0N')0[,XR.C%AWQGFNWHK,9S?B/P3I?BG2+:QU&2[\RV
M<2P7D4NVXB?NRMC@GTQCI@# Q+I?A2WTS1;O37U+5;_[5&T4MU?W1FF*D$8#
M'@8W'&!WK=21)5+1NKJ"5)4YY!P1]001^%#R)$H:1U120H+''). /J20/QIV
M>P&';>%8(=8MM2N=0O[^6S5ULTNI$9;?<,,5(4,Q(XRY8X[U7LO!D-CXQO/$
MRZQJDEW=IY<L,AA\DH/NJ (P0%XP<YXY)R<]-12 XNS^'4-BNMB+Q)KA;6LF
M\9FMR2QZLO[GY3C*\<8/3(!$$WPML9_#.G^'WU_6_L&GS":!0UON##[H+>5D
MA3DC_>.<X&.[HH Y74/!$>I^(=)UN?7M7%YI:%+?88 OS+M<L/*Y+@<]O0"I
M+OP9#>>-+;Q0VL:G'=VR>5% AA\D1G[R8,9)#<Y.<\\$8&.FHH X_7_AQI.N
M^(%UU+[5=+U(H(Y+C3+KR&E4= QP<\<<8. /2MJY\/P2^&VT.VN[ZPA\L(MQ
M:3E)TP<Y#G)W$]2<DY/K6M5.\U*&RN;&W=7>6\F,4:H <85G+')Z *?S'K51
MBY.R LPQ^3!'%O=]BA=[G+-@=2>YK!\3Z-<7EQI>LZ<H?4])F:2*)F"B>-UV
MR19/ ++R"> RC/&:Z&J=OJ,-UJ-[91J^^SV"1R!MW,-P4<YR!@GC^(4*+:;7
M0#-U71+#QAI%HUU'>6DL;K<6TJ_N;BUE'<9!P1R,'(/OQ4NE^'8=.U&;4Y[V
M[U#498A";J[*;EC!R$545549Y.%R3USBMFL&P\6V&H^*;SP]##>)>6D1ED::
M QH5W!?EW8)Y/! P>QJH4IS4G%7LKOR0FTB7Q5X9LO%_A^?1M0EN(K:9D9FM
MV"N"K!A@D$=1Z5LTR63RH7DV.^Q2VU!ECCL!ZU6TK4/[5TR"]^QW=GYH)\B\
MB\N5.2/F7)QTJ>5\O-T&4K3PS96?BS4/$<<MP;R^AC@E1F'EA4Z;1C.?J36?
M%I\^O^+K76[NVEM['2EECL8YEVO-*_RO*5/*J%&U0>3DG@8SU-%2 5SM[X0M
MKC5;K4;/4M1TN>]14O/L3HHN HP"VY&PV.-R[6QWJ3Q!XNT_PY>:?:WD-X[W
MTR01-# 2@9C@ N<*.YQG. 3BMZM)4IPC&<E92V\["NBMI^GVFE:?;V%C L%K
M;H(XHUZ*H_G]3R:CTO3(-(LVMH&D<-+),[R$%G=W+L20!W8_A@5=JAI.J?VK
M;S2_8;VS\J9H=EY#Y;/M_B49.5/8]ZE1;BY+9#,_5/"=KJ.JG5+>^OM,OW@^
MSS3V+JK31=E;<K#CLP 8=C6GI6E66B:7;Z;I\ AM+==D:#G'<DGN2223W)JY
M14@(0&4JP!!&"#WKEK;P#IMLD5HMY?OI$4_GQZ2\B&V1PVX?P[RH;D(6*Y[5
MU5% &3KGAZSUY;5IGFM[JSE\ZUN[<@2P/T)4D$$$<$$$$=12Z)X?M-"6Y:%Y
MI[J[D\VZN[A@TL[XP"Q  P!P   .PK5HH Y23X?:3))-'Y]ZNESW/VN72ED4
M6LDN<Y(V[L$@$INVY_AK9UC2I=6@2%-5U"P0'Y_L3(C2#T+%2R_52IYZUI44
M 4=(T;3]!TV/3],M4M[:/)"+DY)ZDD\DGN3S5ZBB@ HHHH **** "BBB@ HH
MJAJFI_V7%;R?8;V[\Z=(-MI%YA3=_&PR,(.Y[548N;Y8[@7Z***D HHK!U;Q
M;I^C:YIND7,-XUQJ$@CA=(#Y>3ZN<#Z@9(XXK2G2G5ERP5WO]VK$VEN;U%%%
M9C"BFQR1S1K)$ZNC#*LIR#^-.H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KX7UI=NNWZ^EP__H1K[HKX9UW_ )#^H?\
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M:RRX\QPH#/CID]\4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#!U>?_ !VC_A$]._Y^=9_\'5Y_\=K<HH^M5OYG_7R#E1A_\(GIW_/SK/\
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M  =7G_QVC_A$]._Y^=9_\'5Y_P#':W**/K5;^9_U\@Y48?\ PB>G?\_.L_\
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MPII?A&PFLM*C=()9FF*LV[!/8>PK6NK6"^M)K2ZB26WF0QR1N,AE(P01Z8H
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M%U"<Q$^Z%]I_$5TM 'B/Q:^#XU 3^(O#5OB\&7NK)!_KO5T']_U7OVYX/"_
MH22?$^$NQ)CM9<[CR  !BOJBN<MO ^AV?C"7Q1:VQAU"6-DEV-A'+8RQ7^]Q
MU[Y.>:0&[=3?9K2:?_GFA;\A7FNA6IU'7X0V2N\R/SV'/^%=OXJF$/AZYR<%
M\*/S_P#K5A^!;4&2ZNB <813W'<_TI@=K7S-^T!X?&G^+;?5HEQ%?Q8?"\!U
M]3ZD']*^F:\Y^-F@'6_A[<SQINGT]A<ISC '#?7Y<T,#YTL_%UY;> K[PK&6
M\J[NXYN@P% .X>N20GX U]3_  Y\-CPKX%TW3G0)<F/SKGY<'S7Y(/J1PN?]
MD5\V?"3PQ_PDWCZRCEB#V=H?M-P& *E5Z @]06P/QKZ]I( KQ;]H/PP;W1;/
MQ# A,EF?)FP"?W;'(/L <_F*]IJAKFDP:[H=[I=RJF*ZB:,[AD GH<>QP?PI
M@?&OAGQ5?>%VU!K)C_IMJUNXS@<]#TYQS^=?07P$\/G3/!4FIRJPEU&7>,@?
M<7@$?7G\J^=9M!NX/$[:"\;"Z6Y^SE<9.<XS@?G7VGHNFQ:/HEEIT*(B6T*Q
M@(,#('/ZYI(9>HHJ&[MDO+62W=Y461=I:&5HW'T92"#]#3$?+WQ[N5G^)3Q*
MP)M[2*-@.Q.6Y_!A7T'\/O\ DG7AS_L'0?\ H K*O?A!X+U&[DN[[3;BYN9#
MEY9K^=W;C')+Y-;&B>"]'\.^2NE_;X(8L[+?^T)VB&?]AG*_I2 \P^-OPT>^
M1_%&BVVZX09O88QRZC_EH!W([_G5/X/?%E46'PUXBN0JC"V=Y(W3T1S_ "/X
M&O?#R,&N)U3X2>"-7O9+RYT1%GDY8P2O$"?7:I S[XH [5B A/;&:^+YKE8_
MB;-=!L(NKM(&]O-)S7U3:^ ='L[06D%QK"6RC:(EU:Y50/3 ?&*Q_P#A2?@'
M.?[%?/\ U^3?_%T >@5P'Q5^'O\ PG.AHUF435K/+6[/P) >J$]O8^OUS75:
M7X?M-'E+VT^H."FP)<W\TZ*/978@'WK5I@?(_@SQ=K/PK\3S6^H64ZP.0MW9
M2#:WLRY[^AZ&OIGP[XV\.^*8$?2=4MY9&&?(9@LJ_5#S^/2K>M>'-'\0VWD:
MOIMM>)@A?-0$KG^Z>H/N*X6\^ _@NX;-O%>6GM#<L?\ T+-(#H/B?/#!\-=>
M,TJ1[[1T7>P&YB. /<^E>,_LZ?\ (Z:I_P!@X_\ HQ*]"MO@'X/A8&9M0N1_
M=EN, _\ ?(%=KX=\&^'_  I&RZ+I<-JS#:TH!:1AG."YRQ''3- &[7RK\>)4
MD^)MPBG)CMXE8>AVY_D17U)=6RW=K+;N\J+(NTM#(T;CZ,I!!]P:XR]^$'@O
M4KN2[OM.N;FYDY>6:_G=VXQR2^33 O\ PVF2?X;^'V0@A;*-#@]PN#755S6C
M>!=$\/B)-*_M"VAB8LL"ZC.8LGKE"^T_E72,-RE3G!&.#@T >#?M'SKC1+?^
M([W_  Z5T7[/DBM\/YXPP++>N2/3*K_A73:I\+?"FMSK/JMK>WLJ@A7N-1N'
M*CT&7X%.TOX9>&=$\S^R8M0L?,(+_9M2N(]V.F</S2 ["BD50JA1D@#')R:J
M:EIL.J6P@GENHT#!LVUS) W<8W(0<<],XI@?'GC6=8_B9KDZD,JZI*X(.00)
M":^R+)M]A;MZQ*?T%<,WP4\ NQ9M&D+$Y)-Y-S_X_73Z1X7T_0W0V4NH!$3R
MTAFOYI8U'LCN1^E(#9KR3XBR*OQ?\ C(SYS C/JZUZW7,:KX \/:UK4>L7UO
M=27\1!BF6]F0QD=-NU@%_"F!T]%1P0K;P)"C2,J# ,CEV/U8DD_C2RQB:%XF
M+!74J2C%2,^A'(/N* /(?A6RCXH_$52PW&^) SR<2RUZU<WEO:- )Y AGD$4
M8P3N<@D#\@:Y*+X4^$H-0DU"*SO([V1BSW":C<"1B3DDMOR<FKUMX#T.VU:V
MU/%]/<VK%H&N;^:81DC!P&8CI0!QGQZGCA\-Z29& _TY3^ Y->H:=(LNF6DB
M'*O"C ^Q45C>)/ ^@^+FB.MVTURL7*)]JE1%/J%5@,^]5(_AQH$%JMM;MJD$
M"C CCU2Y"@>F-^* (_'NA1>._!&HZ=831O<(V87'(\U"#MS[_=)[9-<_\)_'
MD%[I</A76?\ 0==TY1;B"?Y#,BC"X!Q\P& 5Z\9]<>AZ/I%EH.E0Z;I\1BM8
M0=BERQY))R223R369XC\#>&_%95]8TN*>5<;9E)CDP,\;U(..3QG% '0UCZ9
MXCL]6US5M*M0[2:88UFER"C,X;@$'.5*D'..:PU^&NFK'Y*ZOKXM\;?(&IR[
M,>F,]*Z#0/#FE>&=.%AI-J(( 2<;BS$DD\LQ)/)/4T :E%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .:\;J#HL;=Q,!^AK6T5=NB60](
M5_E53Q7")?#UP2,E,./SQ_6K6ADG0K$GKY*_RH T**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""]@^TV,\&
M 3)&RC/KCBJ/AN3S-"MAW0&/\CBM6L[34-O/>6V $64O& ,<-S_/- &C1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %1&+%TLHQDKM;Z=1_6BB@"6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lnai-20251202.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /aBZs7xRiXgOn8uGanZcSayMaaPtzp51qekxvGZ4fVkqjy8ikNm/3yVQbd+GYVMN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:LNAI="http://lunaibioworks.com/20251202" elementFormDefault="qualified" targetNamespace="http://lunaibioworks.com/20251202">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://lunaibioworks.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="lnai-20251202_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lnai-20251202_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lnai-20251202_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lnai-20251202_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lnai-20251202.xsd#Cover" roleURI="http://lunaibioworks.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lunaibioworks.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LUNAI
BIOWORKS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001527728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2259340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3400
Cottage Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite G2 #32562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sacramento<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-9301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value
    $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LNAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="e7056_8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lunaibioworks.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="e7056_8-k.htm">e7056_8-k.htm</File>
    <File>lnai-20251202.xsd</File>
    <File>lnai-20251202_lab.xml</File>
    <File>lnai-20251202_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "e7056_8-k.htm": {
   "nsprefix": "LNAI",
   "nsuri": "http://lunaibioworks.com/20251202",
   "dts": {
    "inline": {
     "local": [
      "e7056_8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "lnai-20251202.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lnai-20251202_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lnai-20251202_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://lunaibioworks.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e7056_8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e7056_8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lunaibioworks.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001731122-25-001625-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001731122-25-001625-xbrl.zip
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M?__2=LJO)6KJ9P*%4@J'.9A'0PQ3#933J3[E=%X35,$"M7D/AC/!<C O)HC
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ME9'1?J>OO=/ <%V;44><FYCR8*F5ETRP$)>]W6KU]5->++"6(_W>2]->H2&
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M)#<GP;=)*[:8B7&AP62@\WFP1K-KW(J5/C@LJM6*K%F4<%1R\G.&[\=H@8S
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MU?%HQ.S5,( 8OZ,.R1;\^VV]7N1T%0AH#2,OY-Q\KY:)O)8,NQP<K*PQ\?5
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MT?N.[!=B; C\MB!F/5JE3#L2*U7N05!Z)R">%+%PE+TTPG SG:=#]R#FV#D
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MXF?R[#U. LMX)=_A[!L:@X&W)7/PM9"S30Y)(=]D,D<EN\ /H0M9MSX>,%O
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MV>K!&\L@VH4W4OOH^]A>K4N$%%2%K9$B8414UV&(227^GFZH.EP_X2WU1NA
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MOO%]J.(AKMBU1+'R=L^QH54/UFGES+7.5NLI+3B!YL21<T@;3-;(5V47=TW
MC+AN(LLIY19H'JZII*+!Q  <U#42DZX;:LTUPT9V2XQ_*1(LDXY>9,)N<R,I
MFT*UE6/UM8Y$8Q#VT +@ 63/+Q";T%CZ66S<Q)F!Y8J[F<%*737U>D79NQU;
M:R)"G%;"S90@'XR&OSYHR1 ^(<@/'H;AVS(?$'BI+YW/_2MQ\V%:L)M]:H,W
M@+9*;'AX)K$CG>3$V8_NI]-3RF7.,7\)/A2NP94FR8*\2YJ 'TU]R5*A',1I
M@0,GM4(2\,!_64P#80K0]FE[OJ\L32Q:2S*TJYWJJ#7KW6/-MX[@QSQ?)K,Q
M\H#(%<6JK6C X3!$N6,RO.P]W+FWB6]'I5U6/6X5LT=[8C1_!9,7;;.8.!<&
M7+BU&! C1=AGB&IOX3[G+<+[/$V$D2Y5=FGX/IL#'4RD*4"-5RWU&N,0E'91
MII82)WU,JRWNS=[3%2V"AL,8\)L>'PFJ!'Z-8R3<@XMF4="\=<$0C$.I;$JP
M3T$I=#=/3P0%L:"Q%UM&W5XC,IE>*.E"[:JL_,,Z\3YYJQ8E]-ZD'8^%M8
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M5R(BQ:QAK"F# NG4^NA@:B#1P7N2WFLL!P+^3,F=&0<WX8LG=QQ&RB7K#>Z
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MI%B&4^1;+JB[U]U2W+$DKFI3W&K#+STMQ<*IHFY@CZAG3T/(C"LR6?D&0IQ
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M5DHPAA_HC\,2/W+BR_#\S+-E":;=LEA.;<;HHYR87I6YFEPCY84T6\7<(N*
M;U5NZ( MGAHT)3T'F*-@HMB0?(J*E2I"B&#;C,A'G-NH#=LRT8D(6ZBSRNP[
M 8EE5Z.;V(N '89.* K5":\+4RD4WVOLR8Y$$RLQ5ZQ>)2C<58:@\#4<[X7;
MV<&%@%@O_&1*1#SD&>%W&(>24TH_KOCQ".RI^0]B\_9))5Z<'W(N\>+\2S+Q
M\Y+9R7QN[.;3IP4<XH;NG;66L>[AF2N@C;QAANJ=H#%MO>& K$:) M@657*
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MW")#?D+F[6WJ92U@F0QA5ESYKNW47&UP2LSC#9'ZXG_Y!O&EPI2-:&JZ^LP
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MW+30KFT_A _>,5S=@SBR>Z4][Q]TVO/^E[3GYR6SDZ[C8B MR_V9H2"N+HA
M*DO*]M0@;00Q='R&ED128<L7]R935\<QJ/8--/\"GY,K0X7[K$>+87-S,@$W
MRRFJ==':/SUY^P_1TW\"PZ2BH=4Z&23Q4NH$N /N$\RH0[PISM;!6-V"4I#.
M?IBBJ1P=,6\=I+T4A2>1D>!UI:5<)+VN4'Q<2\KJ\"Z'/J@P[Q \75E\]AXV
MV</T!4=8/?A2O'J<L\6<"9Q1@DGX?@BN9=@PA063 AM\7UEF&2&_/#ZR[)?,
M5,T(027OP&]\=]YA<AHO8_  D&(SF^N0P[J%I-=AA59L0/OJ_2[.!:!_@#>M
MK'-?Q/DINTDT]?&Z< %M9EX73.;D0@S%MK!5[T0>Q(T\6:_9VZ:O,JM!I"]$
M?5N1Y(MZX1<98*H6B63:9',85GKMECKY3;?Q<9TU.?[ :+.Z\4%)R;<)%W7R
MAD@<CH^&U6C]3](SAR%%=@^]?^!L1G=.5=B8'U'0% O,5FT&8G='[M;LHXH9
MR*R>$KPBWQ+_C=BM\$^0Y5:;VV9-LU'RM' +XV8O7&#KF7P9<;V.>2UHS2/)
M;H27-B4\$Z$DA Q<*\Q>AE&X0<1&(%E3FX^4D? +EICGYPH;"R)H>1_@IT"1
M,NA$"<]0V7B&?7DL@[U=]=J 'Y\>:J3V;8J"VR3_')-1DKS#T!HW-Z0U?D.M
MB^UF8;>BM3UZ<9:LAWLMT'P=B629V:]VS";RY% JM(RP.X4?3QGU96K@)():
MP[EA+FFDY78QML/8G=M;[KRAVO6IX@;,S@0E:4[M:FH(!9HI+\"EPJ=(@ZE8
MJ)4<^!NJCZ#(:=V6-I+?MP!U5,=';EA*B.:"\B;@NA=##OXRPH>F?U(;@^_]
MWD- ,PR8>37CFEQV!._IJ)6'+^;&SUPBC0077'5=40RN-#^[WIII;2)='B#S
M*M#X/&F<1P_TH69,&S1=:B[9:.Y&B(F\QGIS^H_]UN L>8'MV_-2.#-A'#SM
M#.3O=XF!QB5$[+9]I[W!T3L6IKQ %P)#:69NP72DF'+KX _B3+]_K^@IK/R_
M8KLA:$;9@Z+T8(*9J>K6/PWBE-)(E--HDK^&BWL<3N40$A3!8RQ?1ISR==!V
M@KXH#:"+W'X#+^KU)OAL*I(\*YO9>HD]"&>N#X OLTU<X'#<.W!FFD]SL&%0
MRAIJ[>0*_*;&A2$'[0;Q!G*L4O*2?DVGS;YS PUR-8*:SMHP"9NJ+N_UA0\]
M#,G>;%2R'3SR*=<2?2CY_C5K$7P$!T_89@5)6BPX)5^%)BRUK:R;IL8&A)Q>
M0W&H)"%&62':/]/0"3M8GY(*9NBJHC[EQ>T^;.7[M?&.8T>U@7TL0M%)77 F
M*<EX&.H^%<\WR<7#21Z/1[6.2(D;J>AJ+_!NN*RP2]3Q$6<M<;6>8\GUQ?GI
M/WCNL\R3%Y6=0Y5A ;WX!=E&$BQ(H59)SK$B< =BL?I[MG*UNRT9^4IY0$V=
M_X0-3SY\OT? ]A^SX0<%%O[7O\2$K=]QI.8U\RX;"W8)9GZ'%=_XD8A=NKUN
MQ(.&?3(ITLN)69I'.SFEAHJ>!X)2KBW1F9T9[J^.ZRL<]W.[7BXS#BM0A79!
M[1I:@9S(MBLJ0*8V50O+LPY/7,CN^(AFRY]Q)B0GQ>FLF&Y0=ITFI$6S17V%
M#A-GP2FB6^>*==$Z$]\^+;.L:R=VK2/,6%Z%<&VIMO5S$!U/4*?,]K966P.4
M81#3<;G)RG&013+_5-X\$9[!=</-@$9KX4&E+*@E  ) +!BCQQ- 6\PB=Q@E
MBI,LRQR%!V.2E'10K^6:^<A+S(C/X%'U$O_EFH#07K(]J(Y]-/]MVM[+]<74
M+=L_*M<*<]<)PS[F-Q16I76WF9B*C4B/0]?FJ-TM<T;\10Y/?DL)$)(#_QZ5
M6KQ_Y&6^@T#+]Y'PA[@^)E_T_Z=)%#\XZ$3Q@R^)XL]+9B?3Z?2$^V>ZI))/
MI>2.'KMUK<SOQ&<TDZL9_\(E@G2;2V%2RF5)J90S::VD(F]]GDL#-@/6%J<7
M2VV'T+KDA4](!\F.S+>GV$XV4]6N_2)UW3 TA(T+\:$"1&JSC\A2&]0MZMFV
M]L\Z"+4YF<UF>F?/T:5"P[.4NMV7=76*NUYTI9=-,*7WH1")0.#>@<]D*Y(P
MUP)W5S9ZS8_ W 0J18@!QF0&0R<&EU-_>OCGF9]'R$:%?Y0X4];[J^NJ(:-N
M&!Y:^H*@AHP*C,%N]]*&)=/73$)%!6U""<2!)C%,49+-9XSY*SU"-LZ[\*M&
M2_+%(A#1SO-<^@Q(L.!U@7;FS,KR#\]?O7SKKCJXTI%QM<I!7!9U\SUJAZ[X
MVX\&#_,1U=M5;:W1?GTB8G>;FNC7E$N21[LEA<NIZ%5&.5J-B;2]G 1!).F#
M4@7C,V.V"^ 09\Q!1S=B=]"''5?U!<C0O3'%F/WS+!I]9 TXPT=DGZU <)#A
MB=/MZ KB4_&_TX)8CO-U82JKN5$,OBF_D?CO8 H^=6]&QK]#1P[=-UT@K;7A
MPE&&P@YG)1JH/S$X7RA7/_Z'';.__7B)ZM:7[2:>^"K3RN5^UUZ.=P@NXD/;
M7]MH)(?)AF60 8:BO<X8 I'C+YRA0.%-)J,798^%-UD#NS^DEH@%=YP0++GG
MM^$MZ9CY\4_4K7_%#MO0,*A#O=,5I3,,=@F.I)_LJ%=E54I_<-H&W7^[E=@D
M2C;Q&U3("=>$I4X6(OS9O3^%H34"OC08OEFOQ&SED(X4T73-NKN>KQ>V6!8M
MWJN::W"L;$C[+QC1=*/EZ5ZI4#\24#/_O][NGA:Y3W[;-V<)OW>?_R?+\::H
M,F[\&9S\82/=F7Z4K1P\K:T/J%C!0FG[_B^>^+\I:*8>8,R,N'2] ,5>N720
M2@O0[(''!-\I"5OJ<EZIHV-]'UM&CQ\>8"3+UKI:P3EV',YVU\;2DB;N3+H[
M2-.:*)F!;C@Z21AA2\$]JS@0=9A</+Q/-B_^P'MW\<V]T3&<I$+J.JP^09#!
MX,8!JX *?$6FR?" H58NV"<]%%V[1H=@'B/-K24E"5>E)_X=[;9BB%ZW4/96
M^5>";!:CB!U]ZM5D I.NWZ,V@U3U::2A]SH4),D^X[9@[-S?C_I^!5JY16!6
M&_,6QAB,B#=\.*0HIN<)J@2\%M,K1D@=!MLG76%HN#CPV#*E;C>/C]R]8#;;
M]XOQ77IDSFDXO3:<WPZ>Y-[\F$*3_8;CHQWOE_LSU7/@VR^QB5NVTDPH2@@1
M&/9C"&AES+1B/_GAQ8_2H"K_X:L7/Z8)_$+HF?EG9P>X9ICSH?:NN>K*'6J4
M'C;).)J]*.&!H3$M->_U=&%Z[7J6?(?'X"IWSSL674="?I(OC">X$F#%\'87
MTX^[O^5#$E':+*M?&18<6R1A >@M$K6F$K+=_BKQ@E!N,=8T1-:7U(I?34FK
M._N6^EYF7.9&?Z 71,'MV)9,VMB.G==2FOF>:..MP)!WU7ITT+:?^[V/Q9WU
M(OJH(>?/0+)10CR0" [(#?HLTGQKY#OK:H%&808?7VW8F*_G7BGZ)L;6\,3*
M"(T44<#%G&"Y>NNY.JU41&R@$1Z'Z&7"IX)<**FF:)=2R\/;=YY14[^R[R'E
ME^ V[3JFR=ZG% [TGWI,DSN>4K#I_KQC&G$>N1^V-!UG_X$?1J[H_@?WQ+2D
M"^X^F$M5MM=11[4+,N@B<2K5+.0.7::GCM>#;DCY F%%Q8%F%-S(J?0':[\S
M;QBWB/+W^,@??0^ON"FSY-G3GRY?AYWN@D5@:!_!"79HHSOI'+)OC3&V1_,$
M9RI;2[4+P<G8+O&JR5:$,R$K]L&]!Z:XKV\W"YD-Z3SFEZ@K^[W)MR-?/:%J
M=0E2$F5H;[.WFIX[9HMLC^/3#0O13)D$2:.H13SD'$D]B&#T7NGIAP>=GG[X
M)3W]><GL9"HP6R6$->KN#2SN\=$KE+EA]1\K9G)2BD&0SGO67!Y:=EJ(VSKN
MV4;N3I-4U+LK577G*CVG&X=CU]$I:AH&R7R2<!NT6GOLT^%(_&D"@>,WEQ8(
MX]C84"+CTU!ST5N(\95HJ;@"KO=29A]+AW>1U*71IRVI;%!Q,^K&S0T.7>%3
M!!C 45M>'QZNK%X%-X5[KB0\A/;&>?5,E:'5??R[XGWF*GEC&.%O)T7D1B(.
M/NX[&J9\.&K1R@(P!089*&8X80NO;R]'[LH15]@OC33]ZB_@(Z%_TGB"2"?N
M%F:?A?.-D[?&O <1JAN. ,BNAV(YE$%.<[!D,^[1]&[3OGE9(+77E%>>%D*7
M=);\YGTXNDVI("AX"YAL(#2=4C\-+5EK=1++):8QM" B;H$>Q!4]82#$4U/!
MZT_IH^.C-SZ.QEET47Q//R#:&CW(6Z*MB0VVJM,Y&FT=M(UVO M;*^+O'J3%
M]JG[16GEW]OCLT/;WE3Y9939,:5]Y9+9XM%?P>,4;YU&X.-A"KFLF$!=F"EK
M#FFP.^L]]9 :$//-.=$U\UA6=/Z5!8V*T$J.O((2>2^Y>M_LVO2,[FTSV]D]
M!S+F9$04;LM5&2G^!_N^7CQ(M3RC"7H#N3Y2S+D8YXTX2U[,-7V@S)]ES1-D
M'4<-@;@049$FM6WD:@2>Z38JI:*C@+3WRM"S(.TF#;0Q@[RNN@86N?5W[YP*
M"@7$,L^8QK?&WO.8B"-2SOX'@D;U%.&@R\6MOK"-EI5SCQ84AY!CT:\A@PEH
M+Q_J^IC 9BR*+%?RJ3*Z8-QE+A@*+4/HF=XA.$X)\K#FM2_HD=BXW&4C.0[*
M99*)$I)JD>KK:X>H5$38O+QY-YSOW@$"Y!OE3ROE<YA:/$&D7B:KPG!"AGK8
MQ]7.'&RTP9W$8I2L\5$TDCL22M-9HLH#Q2R52-O#J7,G8\9RT'Y/ ^JX4EJ9
MTF^I!99KV3%@@D/L.FQ??1A7,P.Y?E;FEZ%X2GITRUW<4TZ?[#;>DOHDJ_>O
MNXW'4Z:40S!ITH^XDN]@%ONBVV%Y+:_H"%F57,E:_SWJ]=#Z^<'WNA[BRM(2
M!=RF<BN%62\3;6=V7K[EJY!V=]B8EPZKJI::"OZ"0*!"F;:FXW1-=BNC9*"+
M?+!^:E#1H2?4*1FP75.ZOQ7K;<JIZ)+."U@;0EGU,'Z4]M'>EBZFC=<(UO:S
MTT..&X/"^P[H8>BJ8N!&;&O3ZU722!AE6Y!?:(L5$K7KSIS5*]_^$,MPQYK[
M!IK2*"(4MCWBQXD86">NJL DT+GZT670=Z F(BET NN/!^(_!/P2C0MLO0'V
M0;J$J[5SQ,:R$JL#)[IG^D57O-<F#(D_:LU..!VW8KY^;N-+!9M.MR&CJ1"-
M#+1D'(QKGJN9?FHT.D0+&IB#8"LX3K@ U:E2'HAH8! BZ3G.J]!; LNLB<L'
M[P_>8(Y@C-VH<CUB!O&#=>WQ45_9=G[P02YM8E),X5Q.8F=9?@7ZA($Z6#.H
MCRIM3@PF2RFQPU"F<V;2S!KFUW)Z(<(81<)$_IYKOAQ6:E,MB8("M+S9G!!S
M+-($+FN]PMCQQ7W'(B;9THN'R +07;<<QF8'JF#,E)$:)_-2$ 5JH,5R*SAJ
M34>\T'A<97:!WVM%+\I//V&9KXHB5PN &(&*_ 0+4F[8E<N2BWNG-%)5AR38
M[ ,I^M(1/%P@')&*YSET\VT\ULK7%#7>5FJ>X21<ZPA\GJ,!O-OV*,F/R<'C
M:!S?6M UTHUYU!8_B#.S5ZKQZX-.-7[])=7X><GLY$H8D\EP'9K"".V_+B33
M1MJ.\ 26?2&H,S5-*AHF=43^#"FLZL'BX >EIY72^QD2AX1-7WR+<(K$F,*%
MBPM7N2#()PZ#9>RXSNO%HKY%32Q6.4>/P9*CDD6]]VTG<RE[]!BKUC[==SK"
M"ERYE[#5$=DBJ7^--7 5^<QHV:P34&Q9.2X,3]>SQ1AWQ!T^X$7<&6&$#T%J
ME-6DC]J ,%^/PR<DL0<XO&\PZ(#@M\>V.K3AS7)IGLPV6-.JKZ3+WA<^E ]7
MV'+E/Y6OZ=Z#':6KRB&(T=HT R+'F<?CHG4#&S12M6*0EO-"1I&7[73=M"&)
MH;AY*0GHNNI<(87T1<1\>]WTR]2T8](@,3I^>@:4M : ME].FL]>+R##2>FM
MARL)S]8WD_R$3M>@SL%NK(@N+=Y^^&5.C,REL^5@L;=5HHW%5AP@=Y65T0!A
M,6QU30LR*=^?P/= 26"%PHV*O#F:3LICI7/S49?)B?,6]+J<-;;1(HL\N>E+
MIE,OCJYW1+P<37>S/XZ!F%?S"+DWC61T*%JBH:?9<<(JEUYC:Z4=Y>\C>B@\
MU0J0?3!V&Z,L?FH,<E-Z0;]Z_N+EZTMLA2<M(9^[SA^V-\I^[N:H5))"^:O$
M,@FEDJ&7^'-GH?'\Y*8HES3,P8-QE'2-K;O3>GZZ@@4O.K]G)DXRO,7Z&1-N
M(L[>,(95"[3G^R(P7AAXDDPN3]B;D_IB-B%JFCT\\'\\/$_/S\^EMM^YXJ"^
MXHSUO"2/3R87)W2&[5"Y?ED"-LMUQV1^5.O&N>I^HC<& Q^&6;(=A5]<A4E7
MZ^NPQ/4I?KZ?A!BV,"^=Q<%;(%H'L<*FX!=?(GYGK9UY2\ONE5+VFP0] I?&
M+@H+2@O Z@UF?1V&J9R&X<*'V+&WT<^A'F(U+Z[G%-WAT[R^K=2II'P^'/TK
M 3#?8)OPJT!)&81Y7\?1H&)+3;)Q+T J>\X4=U[8S?<P>A_)5YF\$)E$/FL.
M&FS R7;BTM5=9LY?_WD&QJ,KCD=8@E@P']@_#FSTSL"0@E J(TQ'I9Y48X 5
M[_GJZB <[,DU4YESA/U7:0L0=G<)$V:XH"^+SGTVRB1A;F[Y32ORAHC"#J/'
M(LJ]-Y^)0!_$VI<]3"JW?R<M$HD)3EZ(R">BE 8Z1V"=%/Y3X$(8+*_AOD?-
M+K @;!+HB(A![RQ\:W/S*_Q_M!^N&K'2P4=9:0,8_&/8HPPN>U<]+Y=KK$>!
MC2D/BYYP5!$X?L]U[=66D$GH[?1!K11>*F*$<3M+^(4=$V%@I#[']=.EPIZV
MW\@AFS'+,7\=$V'T_6$WFBF8;55ES,!Y.0>-.WG8P<E[*Q;B4W"PR^6RR$OF
M:PSN;KXC7=XGJ&T6V:'2%E?,'#&MPT:7VE9Q_P%YSY^_@06M;XJN$S\W=BU'
MDE!MO0BWE.Z=P6PF5.W1MZSECZZ(S<0Y/#P91<:N'>.'A6AT,!X*+ OEQ^!-
MZ0<NCIHT0M?B<=#H$?C60=*49?("3O6NSH$2N_^P#A#6-^9S11+BC[8_\_[(
MTU'?]Z3K01\]WE$728XXF%C!&?_$!_I.ISGM-3,+1&EKVZ=]<W D%**FP]X.
MGB,)M5M*54D4*&& ,V;[4B\HXPB)/J6G2]K8V(Z"=? &ZBG 5:=,)[I X:)H
MN9D(%W9LSVGXP<K1RX( $W@@S:QD8=&7N*A4\+ T4!&&LHQI )2,3>-?*ZW<
MG!95,4<C>K7 ZUG^?%O!]79=KNBW[(L*@Q;FF-%,)J'DOX:&LD9IJ_K68&/P
M'*,ZE8J/I8. 2I1ORSH4+@+ DJR /MA%F*)*5HA3Z:^="K3;*EH47D81;CM6
M=%D1:<403PG'>7Y!CA8,&/^'&5IQG <3# XH=?"^VPF5%E+4IXC/%GYB6317
M3+:,!Y,[JK32F8KY>>3HSI7.RJV!$CE2+Y&I'%@.%F$,&&[C&5X&)8//" ',
MN<5=9"0AN2+7,-!@9]FJ)/<E*ZG7E+('84?>#H^CKC_G51U%3PA(V\^RTX8L
MW6U-?EF>;5JOINC<>-*O\D8[\J[!EYKY!@]T(^J98]8-8?WRHF=B&L@<;_Y$
MT0?+#6^#KP?A-.V5E?SFH+.2WWS)2GY>,COYG:E1!6\$SIA%X8Y 4**M-K,>
M[B.$)?LHD^,EQW]0\&U@S-/M$;',T?R)5EQ&"BX-G,(U0>W77L*OXL67/%)?
MUX+ T"SH9P,C672<JA4&"+'&^UR_8BT+TXV),Z:@L[O.MMUV8"@778RX;'VS
MV#0N/0@E.WG'V--UD3QU@<TG-3)99J[[4P0U-9./%)[RUH2TPSAI4]R4,&0P
M0/+US&4+!X2.U$'J2G"B,6,[Z+(72=]/-S;7G0@1 B<)7 (;18$1\EX>N24&
M,YTZF\RP2V"ZN:A*\OLD:4-ED,A=V;IP!%-.>]LH@;=+G62("W3. N;L9N4*
M^\#0P[CO17]IT"T90B8/0SH70G4G3MAS,:1?"U"!?&ROUL:J/ *(-&NR('5%
M.1!N-91$.@W1%OYO5L.P <-/_._CH[T+\BCWPZI,-.- P3M,ZL";O\4B#N6S
M(;?%=RZ)%GJ&N5F)'5UA Q>7,EL4-ZC_.)#&UK)DO&(CH. 2>QR#ERLZ@8YJ
M$+R.D'(R/&&)<1LI#1>PQ&Y*U7Z2B&- 8XOFZ<<%*>N9CAR A8K'-91ND"6Q
M#1P4YZ!,C>Z85JMK'.'X2#HH&B*7,61XZ+H(]R53P@5EIPS]Y0*4-O(<EWCE
M\$N8E"5M/N&4=G&GA?##WH>M9G22B--"J1][L3VL?Z((!\#U=)A_^0M$>%#?
MDVH\X,3E5CFTM=8FH1[)03J,"P*B"[D7&-X?)-0TQT<<X"BH/X-@X5U 3"8I
M[3*;H.."!F:'+XOIX@P+P(89[5ZM"I+)H:414AZB*EY7PH4OA@9S_BYIVA@1
M2I7&@+L'Q.EC^Y4Q&K9'%<]XLRE;\7CS\\;P4Z^TT#L,L*!F6"Q<^:A4="B9
M>,3T\2].?9FHJ*@@1.IZB-.M(X 9"3[X'@9J@#]RYF^:2*1T[ZHP$DPDL:,(
MC*PN B,H\@$KS[$T3IKSZ8,Q:)G[>/E*O)(\Z<6R48C1N+>3ZO//#A6O[YK.
M@ LNL?!/D+YI')C[^#&7\YYWA,P>9;UND3G4.QZ4)%G:#BUV22/F;N8>)#)P
M&/;>4NR] 4:B?90\\<Z>>"6O*M]>PZ;Q^')OVBZ:P\,#6_5S=9G2H]A3H==B
MV\^V[ZX$0T=V2:[Y$$"WI7!M^WLB);_FS,#!Y$W+2/(B=P!+=P12&0 H%R,
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M$G10);:S?V?@'GUE&)(H\GVMRY(60,\$8;%M5''K0K,UMO]*2WQ:RH3O?MI
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M<0!8I7FZJ&MNNF/,D:&^_P(:#[3!'Z0-?F%PXR4B1LCZ&*/;J&HP2N(UX=(
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M@J*66\G1)@P^#\5C<P+A$F%S\Z"XH&45"T*(IQ=-@XT<Y15< Q&#H> P65$
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M"_!"%'E9(KXQ(-"7 0(J31W/YH\GGSZ^^I\?'\%_[H@EV64=XYLLT'6.[XR
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M6LE:O%LK4RMO#LE,_M=.9CI#O*'9?_3ZPYM_0</^HY]/W[][]?]02P,$%
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MUN"%N(LX%@<JJ_ZY3B@Y!MMOU;JEJ\-NFRF+,""28'< /Y7R@_J 9 RZI:%
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M _OR3CW*I><)M%<,18Y2B]98Q 2>GVGNU+V2SZR8'55'_:@%%#UBB1HVBWK
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M2&R+N>'V$W4WX6Q&_"O)@@W ZVPPB0>L-KU^+U_RX]9SJS2/8VA?5&/W2*'
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M'3V%+XH S:'Y0?U&(3"&BC1==(]\W=H-[IMJBW?<+_=MK';+_U!+ 0(4 Q0
M   ( /&K@EMX%/WQ[1H  (.1   -              "  0    !E-S U-E\X
M+6LN:'1M4$L! A0#%     @ \:N"6ZC=88ZBJ@  RXD#  \
M ( !&!L  &4W,#4V7V5X,2TQ+FAT;5!+ 0(4 Q0    ( /&K@ELF]TY!G@H
M /PJ   /              "  >?%  !E-S U-E]E>#4M,2YH=&U02P$"% ,4
M    " #QJX);XDEG;BH#  #Q"P  $0              @ &RT   ;&YA:2TR
M,#(U,3(P,BYX<V102P$"% ,4    " #QJX);F&0V[OT*  !_A@  %0
M        @ $+U   ;&YA:2TR,#(U,3(P,E]L86(N>&UL4$L! A0#%     @
M\:N"6]&']V17!P  WE<  !4              ( !.]\  &QN86DM,C R-3$R
@,#)?<')E+GAM;%!+!08     !@ & 'H!  #%Y@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>e7056_8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lnai-20251202.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001527728</identifier>
        </entity>
        <period>
            <startDate>2025-12-02</startDate>
            <endDate>2025-12-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-12-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-02" id="Fact000004">0001527728</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-02" id="Fact000010">2025-12-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-02" id="Fact000011">LUNAI BIOWORKS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-12-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-12-02" id="Fact000013">001-38751</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-02" id="Fact000014">45-2259340</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-02" id="Fact000015">3400 Cottage Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-12-02" id="Fact000016">Suite G2 #32562</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-02" id="Fact000017">Sacramento</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-02" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-02" id="Fact000019">95825</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-02" id="Fact000020">(424)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-02" id="Fact000021">222-9301</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-02" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-02" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-02" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-02" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-12-02" id="Fact000026">Common Stock, par value     $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-12-02" id="Fact000027">LNAI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-12-02" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-02" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
